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African American men have the highest prostate cancer occurrence and deaths of any 
population, yet many are unaware of screening opportunities or prognoses if diagnosed 
with the disease. The focus of this study was to learn whether a web-based prostate health 
education decision aid would increase prostate cancer knowledge, declared intention to 
be screened, and the likelihood of scheduling a prostate-specific antigen (PSA) test. The 
transtheoretical model of behavior change served as the theoretical framework for the 
study to assess readiness to adopt new behaviors. A total of 128 African American men 
between the ages of 40-65 without a history of prostate cancer participated in the study 
and were divided into 2 nonequivalent groups. The control group had 48 participants, and 
the intervention group had 80.  After reviewing the web-based intervention, participants 
completed a demographic questionnaire, The Prostate Knowledge Questionnaire, and an 
Intent-to-Screen Tool. Mean differences in knowledge change were compared while 
adjusting for covariates using least squares regression. There was no significant 
improvement in the Prostate Knowledge Change score between the experimental and 
control groups. Therefore, the alternate hypothesis cannot be accepted. The social change 
implications suggest that the web-based decision aid studied in this project may not be 
the best tool to increase knowledge about prostate cancer screening.  Therefore, more 
research is needed regarding ways to reach and inform African American men about the 
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Chapter 1: Introduction to the Study  
With the expansion of health care consumerism, there is even greater interest in 
providing medical information to patients. Terms such as informed consent and shared 
decision making are part of most health care providers’ vocabularies (Volk & Spann, 
2000). Most Americans value culturally appropriate and factual health and medical 
education as well being actively involved in choosing their clinical arrangements (Beadle 
et al., 2004). One area in which the medical community values patient input is screening 
for and treating prostate cancer. This screening has been influenced by the growth of 
decision-support technologies, or decision aids, “a mediation arrangement aiding patients 
to reach particular and thoughtful decisions among choices (including the status quo) by 
equipping (at a minimum) data on the choices and consequences pertinent to a person’s 
health situation” (Volk et al., 2007, p. 428 ). Appropriate training helps patients make 
educated decisions regarding their health-relevant actions. The goal of such training is to 
improve physical well-being by promoting health therapy and encouraging healthy 
lifestyles (Bellamy, 2004).  
Prostate cancer is a slow-progressing disease that can remain clinically dormant 
throughout a patient’s lifetime (Schapira & VanRuiswyk, 2000). Garnick (1998) noted 
that before prostate-specific antigen (PSA) testing, most cancers were detected by a 
digital rectal exam (DRE). If the cancer was detectable by DRE, it was usually quite 
advanced. The PSA blood test enables doctors to screen and detect early prostate cancer. 
Treatment options include surgery, radiation, and hormonal therapy. Although medical 




continuing need for health education and awareness to increase early detection rates and 
improve overall survival. 
Although PSA screening has become widespread, it is controversial in some 
circles because randomized controlled trials have not proven to reduce prostate cancer 
mortality (Chan, Vernon, O’Donnell, & Ahn, 2003). The PSA test misses about 25% of 
prostate cancers and gives a false positive result approximately 60% of the time 
(Gambert, 2001). Clinical trials have not demonstrated that the advantages of selection 
and elimination outweigh the hazards. In addition, PSA screening has not been proven to 
reduce mortality (Chan et al., 2003; Jones, 2007).  
Prostate cancer screening entails the primary tests, prescribed follow-up tests 
(transrectal ultrasound or rectal biopsy), and therapeutic medications. In early stage 
asymptomatic patients, treatment can result in numerous complications and decrease 
overall quality of life (Schapira, 2000). Despite these dangers, many family physicians 
believe that PSA screening can decrease prostate cancer-related mortality and morbidity 
(Chan, 2003). 
Most medical professionals suggest that physicians should tell men the risks and 
benefits of PSA screening. The American College of Physicians, the American Cancer 
Society, the American Academy of Family Physicians, and the American Urological 
Association have all urged physicians to help men make knowledgeable choices about 
PSA screening (Chan et al., 2003). Many men are uninformed about the PSA test, despite 




and there is a lack of consensus among physicians and specialists regarding the benefits 
of mass screening (Chan et al., 2003).  
Problem Statement 
The second-leading cause of cancer death in the United States among men older 
than 50 is prostate cancer (Volk et al., 2007). In 2007, 218,890 new cases of prostate 
cancer emerged, resulting in approximately 27,050 deaths (Jones, 2007). Science has 
firmly established that age, race, and family history are risk factors for developing 
prostate cancer (Narla, Friedman, & Martignetti, 2003, p. 1047). The prevalence of 
prostate cancer increases significantly with age. “Basically, every 10 years after the age 
of 40, the incidence of prostate cancer nearly doubles, with a risk of 10% for men in their 
50s increasing to 70% for those in their 80s” (Ellsworth, Heaney, & Gill, 2003, p. 15). 
About 20% of all cancer-related deaths in men over 75 years are due to prostate cancer 
(Volk et al., 2007).  
Prostate cancer affects all population groups, but when compared by race and 
ethnicity, incidence, mortality, and survival rates disproportionately affect African 
American men. Regardless of age, African American men have the highest prostate 
cancer occurrence and death rates among all racial and ethnic groups (Narla et al., 2003, 
p. 1047). It was estimated that 35,110 cases of prostate cancer would be diagnosed in 
African American men and that 5,300 African American men would die from the disease 
in 2011 (Cancer Facts and Figures, 2011).  Prostate cancer is 66% more common among 
African Americans and is twice as likely to be fatal compared to European Americans 




probability of having the disease (Sasagawa & Nakada, 2001). According to the 
Surveillance, Epidemiology and End Results (SEER) program, African American men in 
the United States have a higher rate of prostate cancer (255.5 per 100,000) than do 
European American men (164.4 per 100,000) and are more likely to be diagnosed with 
advanced stages and have a higher mortality rate (Jones, 2007). African American men 
are also 2.4 times more likely to die from prostate cancer than are European Americans 
(Bostwick, 2005).  
Prostate cancer screening and diagnosis are poorly understood among some 
African Americans. Price, Colvin, and Smith (1993) found that only 40% of African 
American men understood their increased risk for prostate cancer. Less than 45% were 
aware that prostate cancer was deadly if not diagnosed and treated, and less than 50% 
were aware that African American men should have a screening examination beginning 
at age 40 years. For these reasons, there is a significant need to improve the participation 
of African American men in prostate health promotion programs (Cowen, Kattan, & 
Miles, 1996). 
Purpose of the Study 
The purpose of this study was to test whether a web-based prostate health 
decision aid could effectively increase prostate cancer screening and informed decision 
making among African American men 40 years and older who have not been diagnosed 
with prostate cancer. In the general population, decision aids lower enthusiasm for 
testing, lower PSA screening rates, and increase the tendency for watchful waiting over 




screening programs, however, decision aids may increase prostate health knowledge, 
screening participation rates, and intent to screen (Volk et al., 2007). Since African 
American men are at high risk for prostate cancer, decision aids could expand personal 
prostate cancer risk knowledge and encourage some men to be tested (Volk, Spann, Cass, 
& Hawley, 2003). 
Nature of the Study 
The role of health promotion guidelines is to lower the morbidity and mortality 
associated with a certain disease and to improve overall quality of care (Mahon, 2003). A 
specific form of health promotion is the decision aid, a formal technique for involving 
patients in decisions about their care by presenting pertinent information about their 
condition or prospects (Volk, 2007). In this study, I tested whether a web-based decision 
aid would be effective for increasing knowledge about prostate cancer, intention to 
undergo screening, and actual screening behavior among a sample of African American 
men ages 40-65 years.  
Niche Marketing, a minority-owned consumer marketing agency in North 
Carolina, provided e-mail addresses of more than 4,000 African American males. The 
company’s expertise is in targeting and marketing consumer-driven products to diverse 
populations, and in their 22 years of doing business, they have amassed an extensive 
database of primarily ethnically diverse consumers. Its customers have included UPS, 
Toyota, Johnson Controls, and many other Fortune 500 companies.  
I sent an e-mail invitation to this population to participate in the study. The 




cancer. A sample size of at least 150 was deemed necessary to ensure that differences and 
commonalities were appropriately represented, as reflected by power analyses. A 
projected sample size of 150 was based on research by Frosch, Kaplan, and Felitti (2003). 
If 75% of the experimental group intended to screen, and 53% of the control group 
intended to screen, the effect size would be 0.25. Per G Power Analysis, a sample size of 
67 in the experimental group and 67 in the control group would have 80% power at the 
0.05 level of significance to detect an effect size of 0.25 (i.e., a difference of 75% versus 
53% between the experimental and control groups). Per G Power Analysis, a sample size 
of 134 is justifiable for detecting a small effect size for this study (Appendix A). 
Dickerson (2006) reported on Pew Internet and American Life Project surveys 
that most U.S. Internet users (80%, or about 93 million) have searched for health 
information and that nearly half (47%) said that such information was useful and 
influenced their health care decisions and provider interactions. Using the Internet for 
health or medical information was more common among those under age 65 years, 
women, European Americans, and those with more years of school and higher income 
(Hesse, 2005). 
Although some studies have tested men’s knowledge of prostate cancer risk 
factors, the specific concept of accurate personal risk has not been widely tested in 
interventional studies (Sheehan, 2009). Watson et al. (2006) indentified perceived risk as 
an important independent predictor of men’s intention to seek prostate cancer screening. 
Schnur et al. (2006) observed that men rated their perceived risk of developing prostate 




supported the hypothesis that men who have a family history of prostate cancer have 
higher perceived risk.  
Research Questions and Hypotheses 
The goal of the study was to learn the answers to four research questions. These 
questions, in turn, generated four hypotheses. 
 Research Question 1: Do intervention groups experience a greater increase in 
prostate cancer knowledge (PCK) than those not exposed to the intervention?  
H10: There is no difference in the PCK change score between the experimental 
and control groups.  
H1a: There is a difference in the PCK change score between the experimental and 
control groups. 
 Research Question 2: Do participants in the intervention group have a higher 
intent to screen (IS) score than those not exposed to the intervention?  
H20: There is no difference in IS scores between the experimental and control 
groups. 
H2a: There is a difference in IS scores between the experimental and control 
groups. 
 Research Question 3: Are participants in the intervention group more likely to 
schedule a PSA screening test than those in the comparison group?  
H30: There is no difference in scheduling a PSA screening test between the 




H3a: There is a difference in scheduling a PSA screening test between the 
experimental and control groups. 
 Research Question 4: Are participants in the intervention group more likely to 
have a PSA screening test than those in the comparison group? 
H40: There is no difference in the odds of having a PSA screening test between the 
intervention and control groups. 
H4a: There is a difference in the odds of having a PSA screening test between the 
intervention and control groups. 
Theoretical Framework  
The transtheoretical model (Prochaska & DiClemente, 1992) provided the 
theoretical framework, one based upon the initial model used for smoking cessation from 
the early 1980s (Prochaska, 2008). From that time, the model was improved and tested 
further to add cervical cancer screening and other health behaviors. It also was improved 
to include the three stages of readiness for change: the decisional balance, self-efficacy, 
and stages of change. The adaptation further improved that model to convey six stages of 
change with respect to readiness. These six stages were as follows:  
1. Precontemplation.  
2. Contemplation. 
3. Preparation.  
4. Action.  
5. Maintenance. 




Tung (2008) noted the relapse stage and self-efficacy were an indication of the 
ability of an individual to execute a behavior that was important to achieve a given result 
(Bandura, 1990). The perceived benefits, in addition to the perceived costs or barriers that 
a person derives, were the decisional balance with respect to executing behavior 
(Prochaska, 2008). The model of health belief and theory of behavior proved to be 
modestly successful in predicting the probability of prostate cancer screening (Weinrich, 
2001). As a result, and since the TTM was found to have been successful in predicting 
breast cancer screening, the application of the model to prostate cancer screening is 
warranted (Sheehan, 2009).  
Definitions of Terms 
Digital rectal exam (DRE): Insertion of a gloved, lubricated finger into the rectum 
of a male to feel the prostate and check for any abnormalities American Urological 
Association (2008, p.10). 
Intent-to-screen tool (IST): A one-question tool used to assess a person’s intention 
to participate in a prostate cancer screening program postintervention. Term established 
at the following site: http://www.ncbi.nlm.nih.gov/pubmed/21243659. 
Prostate cancer: When there are cells that grow fast and abnormally, and those 
cells are located in the prostate, prostate cancer is the resulting diagnosis. These 
abnormally growing cells quickly divide and generate new cells that are not biologically 




Prostate-specific antigen (PSA): PSA is a protein generated by the prostate gland. 
It is made only by the prostate gland, and high levels of PSA in the blood can be a sign of 
cancer of the prostate (AUA, 2008, p.10).  
Prostate Cancer Knowledge Questionnaire (PCKQ): An eight-item survey used 
to gather demographic data and prostate cancer pre- and posttest knowledge (Weinrich, 
2004).  
Screening: Tests that identify a disease early to improve the chances for cure and 
prevent complications from the disease (AUA, 2008, p.11). 
Assumptions 
I assumed that the sample of African American men would be representative of 
the population targeted by the study. I also assumed that the postintervention sample 
would be close enough to the preintervention sample with respect to the completed 
surveys that enough data would be generated to meet the critical number of usable 
surveys required for the analysis. In addition, I assumed there would be a high degree of 
accuracy in both collected data and supplied data from the participants. 
Limitations 
In any study, it is important to assess whether the results could have been 
influenced by bias. Bias can be introduced through the methods used to identify and 
recruit subjects (selection bias), the measurement of information (information bias), or 
through confounding (Ellison, 2008). Potential limitations of this study are selection and 




The sample was limited to approximately 150 participants. Most data collected 
were self-reported. Recall bias may marginalize self-reported data. Spain (2008) noted 
that recall regarding checkups and PSA tests can be influenced by subsequent events such 
as patient care and treatment. Data collection represented but a single point in time. 
Participants completed surveys at their leisure, and the process may not have commanded 
their complete attention. Unsigned surveys or those with less than 75% of the survey 
completed were not counted. These criteria produced a smaller population, which could 
have limited the generalizability of the results. 
Delimitations 
Study delimitations should be considered when interpreting the results of any 
study. Unknowns include whether participants volunteered and whether they had access 
to the Internet and a valid e-mail account. An additional unknown was whether the 
participants were computer literate and able to read, understand, and comply with 
instructions. 
Significance of the Study 
Prostate cancer screening, although controversial, can detect prostate cancer many 
years before a patient presents with symptoms. Typically, men who develop prostate 
cancer die of other diseases; however, this is not the case for African Americans, who 
have a strong genetic predisposition to prostate cancer (AUA, 2009). Screening-detected 
cancers are predominantly early disease, for which the prognosis is considerably better 
than that of clinically detected prostate cancer (Etzioni, 2002). Many men with a family 




et al., 2005). Specifically, African American men are less likely to appreciate family 
history and other prostate risk cancer factors than European American men (Steele, 
2000). Given that African American men are diagnosed with more advanced prostate 
cancer than are European American men and have a demonstrated lower awareness of 
prostate cancer risk factors, improvement of risk awareness among African American 
men merits exploration. Given the vulnerability of this population, the lack of medical 
consensus around screening guidelines, and strong genetic predisposition to prostate 
cancer, there is a need to learn ways to lead them to make good choices about their health 
care. Early detection can save more lives, and the lives of these men and their families 
should provide positive social change not only for the population they are a part of but to 
the medical community. Thus, without medical screening consensus and the continued 
proliferation of prostate cancer morbidity and mortality, the social change of increased 
quality and length of life of African American males will likely not be realized.  
Summary and Transition 
My purpose was to test the effects of a web-based decision aid on the knowledge 
and behavior of African American men regarding prostate cancer screening. The study 
was based on the transtheoretical model, which assesses people’s readiness to adopt new 
behaviors. The sample was 150 African American men over 40 years who do not have 
prostate cancer to see whether the web-based information would increase their awareness 
of prostate cancer prevalence, morbidity, and mortality, as well as screening and 
treatment options, and to increase the rate of prostate cancer screenings among African 




decision aids, especially with regard to African American men. Chapter 3 is the 
description of the study methods, including research design, population and sample, 
instrumentation, data collection and analysis, and steps taken for the ethical protection of 
participants. The results, data analysis, and interpretation comprise Chapter 4, and in 
Chapter 5, I will include a discussion of any robust findings and recommendations for 




Chapter 2: Literature Review 
The purpose of this study was to measure differences in screening intent and 
actual screening behavior in African American men who are initially diagnosed with 
prostate cancer in its more advanced stages more often than members of other racial 
groups. Inadequate screening for prostate cancer in African American men reflects a lack 
of agreement on screening guidelines, which can then result in mixed messages to health 
care practitioners and patients. Other barriers to screening include lack of health 
insurance, reluctance to participate in research, and fear (Woods, 2006). One of my goals 
for this study was to determine the role such barriers play in health care decisions made 
by African American men. 
In this chapter, I present reviews of the relevant literature on prostate cancer, 
screening, decision aids, and health care attitudes and behavior of African American men. 
The review includes an exploration of the literature regarding the incidence, prevalence, 
morbidity, and mortality rates of prostate cancer in the general population and among 
African American males in particular. Also explored is the incongruence regarding 
prostate cancer screening guidelines and recommendations, including a discussion of 
African American male screening behaviors, the role of decision aids on screening 
behavior and participation, and the study variables. Since this intervention is Internet-
based, I also discussed the role of the Internet in providing health information.  
 The review includes EBSCO databases at Walden University, Abbott 
Laboratories, and the University of Wisconsin–Parkside. I also searched Medline, 




The initial search yielded more than 16,600 peer-reviewed articles. I excluded case 
reports, commentaries, editorials, and reviews. Keyword searches used the following 
terms: health promotion(s), prostate cancer and decision tools, prostate cancer and 
decision aids, decision aids, decision aids and health promotion(s), informed consent, 
health education, shared decision making, informed decision making, informed consent, 
transtheoretical model, PCK change, prostate cancer intent to screen, and prostate 
cancer screening behavior. 
Organization 
The literature review includes a discussion of prostate cancer prevalence in the 
United States, prostate cancer screening, prostate cancer and African Americans, and 
literature on informal communication about the influences on African American men and 
their health-seeking behaviors. I also sought information on the issues surrounding low 
participation of African American men in research studies and the general distrust 
African Americans have for the medical profession. The transtheoretical model and its 
application to both health-seeking behavior and cancer screening-seeking behavior is 
followed by a discussion from the literature relating to decision aids.  
 The literature review continues with a discussion of the appropriateness of the 
methodology and data analysis selected for this study, presentation of the dependent and 
independent variables, and the use of the Internet for health information. It also includes a 






The incidence of prostate cancer in the United States has decreased and the 
overall 5-year survival rate is 96% for African American men if the cancer is detected at 
an early stage (National Cancer Institute, 2012). Despite these trends, prostate cancer is 
still the most common noncutaneous cancer and the second-leading cause of male cancer 
mortality (Cancer Facts and Figures, 2011). During 2012, there were an estimated 
241,740 new cases and 28,170 deaths from prostate cancer (National Cancer Institute, 
2012). One in six men will be diagnosed with prostate cancer in their lifetime (Cancer 
Facts and Figures, 2011). Further, prostate cancer is the most common nondermatologic 
cancer in men aged 50 years and older (Wilbur, 2008). Wilber (2008) noted that on 
average, men have an approximately 17% chance of developing prostate cancer at some 
point during their lives.  
African American men are disproportionately affected by prostate cancer and 
have one of the highest rates of this cancer in the world (Jones, 2006; Toles, 2008). 
According to SEER, a program of the National Cancer Institute, African American men 
were found to have an increased rate of cancer of the prostate (255.5/100,000) than 
European American men (161.4/100,000), Asians and Pacific Islanders (140.9/100,000), 
or Hispanics (140.9/100,000). With respect to men of other races, men of African 
American descent were found to be more likely to have received a diagnosis later along 
the disease progression path and have an increased mortality rate (Epsey et al., 2007).  
In a clinical trial that examined the outcomes of 288 African American and 975 




Americans had poorer prognoses than European Americans and that prostate cancer was 
diagnosed at more advanced stages in African Americans. Although the incidence of 
prostate cancer in African American men has decreased from its high in 1993 (343.1 per 
100,000), the rate remains over twice that of European American men. One of the 
strongest risk factors for developing prostate cancer is family history, which is especially 
true for African American men, who are more likely than members of other racial and 
ethnic groups are to have aggressive forms of the disease (Alton, 2008). 
Several issues regarding prostate cancer screening could potentially be 
counterproductive in terms of overall costs of unnecessary procedures and false positives 
(Wilbur, 2008). Limitations of DRE and PSA tests have indicated that their reliability is 
relatively poor and that outcomes for those tests are not sufficiently. As a result, expert 
recommendations regarding prostate cancer screening can vary.  
Prostate Cancer Screening 
The literature reviewed for this study included the relationships between prostate 
cancer screening and factors contributing to lack of screening participation among 
African American men. Several researchers explored belief systems that comprised the 
major theoretical foundation for this study and how health-seeking behaviors may 
influence decisions to participate in screening examinations. The review also revealed 
research that established a basis for continuing distrust among African Americans for the 
medical and research professions (Clarke-Tasker & Wade, 2002; Gray et al., 2005; 




 There is also a significant difference between African American males and 
European American males with respect to models that would provide an increase in 
education leading to prostate cancer screening (Barber et al., 1998). The authors 
investigated the efficacy of an educational cancer screening program in an urban 
community in the Midwest containing 944 men. The authors were able to provide rectal 
examinations digitally and PSA blood tests free of charge due to a grant (Barber et al., 
1998). Prior to screenings, an educational intervention was used to stress the importance 
of early detection of prostate cancer. The authors administered a short survey both before 
and after the educational video and screenings. The questionnaire concentrated on 
attitudes and knowledge regarding prostate cancer screening (Barber et al., 1998). The 
results of the pretest showed that African American males were significantly less likely to 
identify early symptoms of prostate cancer and components of a prostate cancer 
screening. Importantly, the authors found that after the educational video, all races 
exhibited an increased knowledge, and the differences among races diminished to the 
point of not being statistically significant.  
 Barber et al. (1998) found that radio was the best means for reaching African 
Americans for prostate cancer screening, while for European Americans, newspapers 
provided the broadest reach. Further, minorities were found to have a preference for 
private appointment screenings. The study provides further evidence that there is a 
significant need for targeted and customized prostate cancer education, appointment, and 
screening methods that can be applied to African Americans to increase their propensity 




 While researchers such as Barber et al. (1998) have concentrated on 
methodologies for increasing the reach of prostate cancer screening education, there is 
some evidence that screening may not be as effective as some believe and may be too 
costly to apply it broadly. As noted in the study by Wilbur (2009), there remain some 
validity issues with respect to the outcomes of screenings such as false positives. These 
results can increase costs and have deleterious effects on the patient who receives a false 
positive diagnosis, as it may result in increased stress on the individual and unnecessary 
costs associated with treatment (Harisinghani et al., 2003).  
Wilbur (2009) indicated that there is a variety with respect to expert 
recommendations of screening for prostate cancer and found that research indicated too 
little evidence generated to provide a positive or negative recommendation for DRE or 
PSA screening. Two examples of the variety of recommendations include both 
conducting universal screenings for all men over 50 years as well as waiting until the age 
of 75 years to begin screening since prostate cancer screening before that age resulted in 
few if any benefits. This finding and others in the literature suggests the wisdom of an 
individual approach to prostate cancer screening rather than a blanket recommendation to 
promote screening or recommend against it. 
A study by Potosky et al. (1995) considered aspects of screening comingled with 
the rate of prostate cancer. This study specifically investigated the increases in prostate 
cancer diagnoses from 1986-1991. The authors randomly sampled 5% of male fee-for-
service patients in Connecticut, Georgia, Michigan, and Seattle--approximately 6% of the 




prostate cancer diagnoses could be attributed simply to the increase in screening 
behaviors, mostly PSA tests but to a lesser extent, transrectal ultrasounds conducted 
during those years. This finding indicates that there may not be a rise in prostate cancer, 
but rather a rise in detection, which also increases treatment and presumably reduces 
morbidity.  
African American Men and Prostate Cancer 
The differences in prostate cancer between African American men and other U.S. 
men have been attributed to diet, genetic variability, and social status. Some researchers 
have attributed differences in mortality and morbidity to a delay in or avoidance of 
interacting with the health care system (Toles, 2008). Toles (2008) found both perceived 
and real barriers to seeking care and concluded that African American men are aware of 
their vulnerability to prostate cancer but are doubtful about its cure. A commonly cited 
source of distrust of the American health care system among African Americans is the 
Tuskegee Syphilis Study, in which 400 participants were not offered the known cure for 
syphilis (penicillin), even after the study had been completed.  
In a study of recently diagnosed prostate cancer patients in North Carolina, 
Talcott et al. (2007) identified several barriers to early-stage prostate cancer diagnosis in 
African American men: insurance coverage, inconvenient health care access, less job 
flexibility to obtain screening and care, and weak ties to their primary physician. They 
concluded that “African American men’s distrust and underutilization of PC-related 
medical and preventive care arise not from researchers’ past misdeeds, but from 




economic and social circumstances” (Talcott et al., 2007, p. 1606). Talcott et al. also 
found significant differences in knowledge, attitudes, beliefs, and physician trust based 
on race. African American men were more likely than European Americans to believe 
that their chances of getting prostate cancer were small, and African American men 
revealed greater distrust in their physicians compared to European American men. 
Men with a family history of prostate cancer are at higher risk for contracting the disease, 
and African American men in particular are less likely to be aware of this higher 
vulnerability (Spain, 2008). Spain (2008) concluded that if African American men are 
made aware of the risk factors for prostate cancer, they will more likely be screened, 
thereby reducing the tendency to be diagnosed at more advanced stages of the disease. 
Toles (2008) emphasized the importance of health promotion messages that are culturally 
sensitive to African American males. Although several decisions aids have been 
developed for prostate cancer screening, few have been evaluated in trials, and none 
measured actual follow-up behavior (Volk et al., 2007). Volk et al. (2007) noted that 
“prostate cancer screening decision aids appear to decrease interest in screening and the 
intention to be screened, decrease PSA testing rates, and increase preferences for 
watchful waiting over other treatments” (p. 432). Studies of African American patients, 
however, suggest that aids may slightly increase screening rates. 
Informal Communication 
There is limited literature on the impact of informal communication and how it 
influences health-seeking behaviors among African American men. The importance of 




studies about recruitment that began in churches, barbershops, and fraternal organizations 
(Cowart, 2004; Kleier, 2003; Parchment, 2004; Toles, 2008), thus recognizing the 
influence of these institutions as sources to provide communication within African 
American communities. Evidence of the church’s importance in African American 
communities is seen from its role in civil rights movements, establishing food and 
clothing programs, and advocating for communities by political and educational 
involvement. However, the barbershop is another source of informal communication 
within African American communities that may have greater influence among African 
American males (Cowart, 2004; Franklin, 1985; Toles, 2008).  
The African American Barbershop 
For many African American males, barbershops are an environment that exudes 
African American masculinity. The barbershop is also a major source of socialization and 
communication within the community. Barbershops for younger African American males 
serve as an institution where sex-role expectations are modeled, confirmed, or explained 
(Franklin, 1985). In 1983, Franklin (1985) observed and recorded narratives, behaviors, 
and attitudes of African American males patronizing a Midwestern city barbershop 
during a 2-month study of male socialization utilizing perspectives of Bandura, Kohlberg, 
and Freud to describe the development of male sex roles. The importance of the 
barbershop to this study is that the patrons represented a wide stratum of African 
American socioeconomic classes, and while in the barbershop, nearly all patrons engage 
in overly masculine behaviors. Sexual prowess is typically exaggerated, and misogynistic 




contribute to discussions. Those disagreeing by voicing equality between the sexes or 
professing a commitment to fidelity were silenced or ridiculed. African American 
healthcare and education professionals who know how barbershops influence African 
American male socialization have used these establishments to promote positive health-
seeking behaviors (Cowart, 2004; Lewis, Shain, Quinn, Turner, & Moore, 2002; Majors, 
2003; Toles, 2008). For example, in 2001 public health officials in Durham, North 
Carolina, became alarmed when 88% of the HIV cases for 1 month were reported by 
African Americans. Aware of the strength of informal communication, health officials 
instituted a barbershop and beauty shop awareness program in places that would demand 
the attention of those within the communities to promote safer sexual practices. The 
program was reported as a success (Lewis, et al., 2002). Two years later, Cowart (2004), 
discouraged with traditional medical communication practices, developed and 
implemented a program to foster prostate cancer awareness for African American 
men in the setting they most frequently congregate, the barbershop. The program found 
men with limited knowledge of prostate cancer and hungry for knowledge and attention.  
Low African American Participation in Research Studies  
It is surprising that the literature regarding prostate cancer and African 
Americans is not distinguished from prostate cancer research involving the general 
population (Cowart, 2004; Gray et al, 2005; Newton, 2002; Pierce et al., 2003) since 
African Americans are more likely to develop the disease and have a higher mortality 
than other ethnicities (ACS, 2006; NCI, 2006; Nivens et al., 2001). Countless studies 




prostate cancer screening. An earlier study by Gray et al. (2005) supports a major premise 
of this study that holds African Americans accountable for low participation by referring 
earlier research where screening costs are low or free and found African American 
participation lower than European American men (Nivens et al., 2001). The review 
uncovered research showing a correlation between possible health beliefs of African 
American men and screening practices (Lu, 2007; Plowden, 2006). In an earlier study to 
determine if discriminatory medical practices were responsible for the difference in 
deaths of African American and European American males. Demark-Wahnefried (1998) 
found some African American males were aware of prostate cancer dangers and avoided 
screening due to beliefs of susceptibility. Specifically, the men did not believe themselves 
to be susceptible to prostate cancer or adopted a fatalistic view of prostate cancer as an 
automatic death sentence. 
African American Distrust of the Medical Profession 
Among African Americans, there is a mistrust of the medical and mental health 
professions resulting from slavery and institutional racism and the treatment of African 
American men: “The institution of slavery undermined African American men’s sense of 
trust, power, and control” (Wilson, n.d., p. 5). African Americans attempting to escape 
from servitude during slavery were considered “mad” or “crazy” (Moffic, 2003, p. 1). In 
matters related to prostate cancer screening, Gilligan et al. (2004) studied 67,000 men 
over the age of 67 and found that African American men examined by physicians were 
35% less likely than European American men to get a PSA test. Studies support 




prostate cancer screening with them (Clarke-Tasker & Wade, 2002; Siegal et al., 2007). It 
would appear that given these findings, the medical profession must accept some 
responsibility for screening deficits. An implication that may be drawn from studies 
citing a reluctance to participate in screening, specifically digital rectal examinations, 
may find non-African American physicians hesitant to perform digital rectal 
examinations on African American men.  
Oliver (2007) found that African American participants in a rural Alabama 
community were uncomfortable when examined by older European American physicians. 
One participant’s perception was, “White gentlemen have created that uncomfortable 
zone over the years, and it has been difficult for them to practice and talk to Blacks” 
(Oliver, 2007, p. 78). Studies of medical and pharmaceutical responses to minorities 
revealed ongoing disparate treatment of African Americans and other minorities 
(Burroughs, Maxey, & Levy; 2002; Gamble, 1997; Intercultural Council Cancer Facts, 
2003; Smith et al., 2007).  
As a matter of general applicability to African Americans and medicine, 
Morrison, Wallenstein, Natale, Senzel, and Huang (as cited in Intercultural Cancer 
Council Cancer Facts, 2003) found that pharmacies in predominantly African American 
and Hispanic neighborhoods do not carry a sufficient stock of prescription pain 
medication for patients. Outpatient cancer treatment programs in minority neighborhoods 
also provide lower levels of service to African American and Hispanic patients 
(Burroughs et al., 2002; Cleeland, Gonin, Baez, Loehrer, & Pandya, as cited in the 




The prescribing of medication and patient compliance is influenced by culture. 
Research revealed that medication provided to minorities, African Americans in 
particular, is often based on physicians misdiagnosing a condition and inappropriately 
prescribing medication that labels African American patients with a condition that would 
not be diagnosed in European Americans having similar symptom (Suite, Bril, Primm, & 
Harrison-Ross, 2007). For example, “African American patients are more likely to be 
over diagnosed as having a psychotic illness and treated with antipsychotic medication 
regardless of the diagnosis” (Burroughs et al., 2002, p. 11). 
The decision to participate in screening programs is further complicated because, 
prostate cancer screening is controversial due to the low sensitivity and specificity of the 
PSA and DRE tests (Jones 2007). The PSA test misses about 25% of prostate cancers and 
gives a false positive result approximately 60% of the time (Sheehan, 2009). Prostate 
cancer screening has also been controversial because of the lack of evidence that 
screening reduces mortality from the disease (National Cancer Institute, 2008). As a 
result, current prostate cancer screening recommendations vary. The NCI (2008) and the 
2008 United States Preventative Services Task Force (USPSTF) concluded that there is 
insufficient evidence to recommend screening with DRE and PSA. The USPSTF recently 
updated its recommendations to advise against screening for men over age 75.  
The American College of Preventive Medicine does not support routine screening 
using DRE and PSA (Ferrini & Woolf, 2008). The American Cancer Society (ACS) and 
the American Urological Association (AUA) have a more aggressive approach to 




and beginning at earlier ages for men with risk factors (ACS 2008; AUA 2008). The 
USPTF observed that average-risk African American males between the ages of 50 to 70 
years and men over 45 years of age will receive the greatest benefit from screening (Ross 
et al., 2008). The 2005 National Health Interview Survey found that 23.0% of African 
American men ages 40-49 years had had a PSA test, compared to 15.6% of non-Hispanic 
European American men and 12.8% of Hispanic men (Ross et al., 2008).  
One problem confronting health care practitioners who are initiating 
conversations with their patients about prostate screening is differing recommendations 
among organizations. Screening based solely on PSA levels is controversial, as the 
readings can lead to the discovery of disease that is inconsequential or to the need for 
more invasive follow-up testing. Explaining PSA levels to patients is challenging, given 
the complexity of interpreting the results to the patient. Screening results may require 
more invasive follow-up and delayed benefits. Screening aids are often not tailored to the 
individual, and too few persons benefit from screening (Barratt, 2004). 
The purpose of screening is early detection, lack of which is the primary problem 
for African American men with prostate cancer. But PSA testing results vary, and there is 
the element of uncertainty in their results. Reflecting this uncertainty, the AUA (2009) 
suggested, “The risks of over detection and overtreatment should be included in [a] 
discussion” and that PSA screening should be recommended “for well-informed men who 
wish to pursue early diagnosis” (AUA, 2009, p. 7). The AUA further recommended, “All 




many screen-detected prostate cancers may not need immediate treatment” (AUA, 2009, 
p. 7). 
The goal of early detection is to reduce the overall morbidity and mortality of 
prostate cancer. The European Randomized Study of Screening for Prostate Cancer 
(ERSPC), in fact, indicated that the decrease of the risk of diagnosis of prostate cancer 
was achievable in addition to being linked to a reduced probability of 20% of prostate 
cancer deaths (Schroder et al., 2009); however, it also noted that over diagnosis could be 
linked to the frequency of the screenings. The AUA (2009) indicated that survival over a 
longer period was reduced by the diagnosis of prostate cancer. This prostate cancer 
finding was linked to the spread of the cancer past the prostate. Generally, persons with 
cases that are similar to these have been found unlikely to experience improvement with 
therapy than with a reduction in the volume or type (grade) of the tumors (AUA, 2009). 
The AUA (2009) also found no overarching and agreed-upon distinction with respect to 
significant and insignificant prostate cancer.  
There is some agreement that PSA testing is linked to a significant increase in the 
number of males diagnosed with cancer of the prostate (Jemal, 2008). “Subsequently, 
prostate cancer incidence rates in the United States have fallen but are still twice the rates 
recorded prior to the introduction of PSA testing” (AUA, 2009, p. 12). The use of such 
testing was also found to be linked to the decrease in age of the diagnosed males when 
compared to the age of males before PSA testing was as widely used. This has also not 
reduced the fact that previous literature has demonstrated that the risk of developing 




dying was found to be 3.4% (Epsey, 2007). Although many men have latent prostate 
cancer, they are not destined to die from the disease. 
Widespread testing using PSA has increased the concern about detection of 
cancer of the prostate (AUA, 2009) because the screening can indicate a condition that 
would cause no deaths and that might have remained undetected had the patient not 
undergone the test. An additional downside of these tests was that they are better 
equipped to detect tumors that grow slowly rather than those that are aggressive. Some 
bias is reduced with repeated testing, but “the likelihood of detecting smaller, more 
indolent tumors that will never progress to clinical significance remains high” (AUA, 
2009, p. 14). 
It was also found that mental in addition to physical stress could increase 
following biopsy. It was noted that males with prostate cancer that were found to be 
clinically significant had more complications related to treatment (Sanda et al., 2008). 
Other factors could potentially impact the levels of PSA and, as a result, should be 
considered when the results are evaluated. Three of the common diseases of this type 
could be linked to increased levels of serum PSA, and increased PSA levels are also 
linked to prostate biopsies (AUA, 2009).  
According to Weinrich, Holdford, Boyd, and Crenaga (2001) the following are 
reasons PSA and DRE screening are not necessarily conclusive:  
1. “The PSA assay is prostate specific, not cancer specific. . . . Elevations in PSA 





2. PSA testing is affected by several variables, including age and race. 
3. “A DRE . . . can detect subtle prostate abnormalities, including symmetry, 
consistency, and marked induration of nodules. . . . Even though the DRE is less 
effective than the PSA in detecting prostate cancer, it is still recommended” (p. 
81). 
4. Screening results in false positives and false negatives. 
5. There is a lack of national consensus with regard to age range and 
recommended repetition for prostate cancer screening. 
6. “Differences in prostate cancer screening guidelines are related to the inability 
to estimate which of the prostate cancer cases will remain relatively slow growing 
and which will cause illness and death” (p. 82).  
African American men are less likely to undergo screening for prostate cancer 
than are members of other racial and ethnic groups. That gap has been attributed to 
differential access to health care services and cultural barriers. Studies have shown that 
increased awareness and knowledge about prostate cancer leads to decreased screening in 
majority populations, but this is not the case for the small number of African American 
men who have participated in these studies. Most of these studies, though, have targeted 
primarily European American men. 
Transtheoretical Model (TTM) 
That perceptual and environmental factors such as exposure to health education 
influence health-related choices has been proposed TTM (Prochaska & DiClemente, 




fundamental concept of the transtheoretical model (TTM) is that behavior change is most 
successful when specific behavioral strategies, called processes-of-change, are applied at 
the right time, or during the appropriate stage of change” (p. 36). Spencer et al. studied 42 
stage-matched mammography interventions and found that the stage-of-change and 
decision balance appear to apply only to breast cancer screening behavior and suggested 
that more research is needed on the application of TTM to all cancer screening behaviors.  
The application of the transtheoretical model to cancer screening behaviors can be 
adapted from the Rakowski et al. (1997) stage-of-change definitions, which are as 
follows:  
1. Precontemplation: No previous mammogram and no plan to get one within the 
next year or two.  
2. Relapse: Had a mammogram more than 24 months prior but has no plan to get 
one within the next year or two.  
3. Contemplation: No previous mammogram within the past 24 months but plans 
to get one within the next year or two.  
4. Relapse risk: Had a mammogram in the past 24 months but has no plan to get 
one within the next year or two.  
5. Action: Had the first mammogram within the past 24 months and plans to have 
another within the next year or two.  
6. Maintenance: Has had two or more mammograms on schedule (no more than 
24 months apart) and is planning to have another within the next year or two 




 These TTM categories of the stage-of-change definitions can be applied to 
prostate cancer screening in African Americans. Citations involving Rakowski comprised 
over 15% of the Spencer et al. (2005) critical literature review, confirming Rakowski as a 
cited expert and that properly applying his work would add validity to further studies 
applying the TTM to cancer screening behavior.  
In addition to mammography, the model has been used to determine predictors 
and variables associated with screenings such as cervical and colorectal cancers (Honda 
& Gorin, 2006; Kelaher et al., 1999; Rakowski, Dube, & Goldstein, 1966). Trauth et al. 
(2003) more recently applied the TTM to the colorectal cancer screening behavior among 
a population of two lower income communities in Pennsylvania. The use of the model 
involved categorizing the individual participants based upon their stage of readiness to 
undergo either one of two colorectal screening exams. Trauth et al. conducted a telephone 
survey of 414 respondents and found relationships between the colorectal cancer 
screening test behavioral change and factors such as recent doctor checkup, age, gender, 
prior doctor recommendation, history of prostate antigen blood testing, chronic need for 
prescription medications, and history of cervical Pap smear testing. The successful 
application of the colorectal cancer screening behavior with respect to the TTM further 
demonstrated the efficacy of its use in this study.  
More generally, Prochaska and Velicer (1997) researched the application of the 
TTM to health behavior changes rather than behavior changes directly applied to cancer. 
Use of the model shows both its breadth of applicable uses and its readily apparent 




the TTM explicitly models behavior change through six stages of precontemplation, 
contemplation, preparation, action, maintenance, and termination. Rakowski et al. (1997) 
adapted these more general stages to their study of mammography behavior. Prochaska 
and Velicer also identified an additional four stages of change that were identified with 
respect to the production of progress along with decisional balance, self efficacy, and 
temptations. The study also provided a useful rule of thumb with respect to at-risk 
populations that include African American males, positing that approximately 40% of at-
risk populations were in precontemplation; 40% were in contemplation, and 20% were in 
preparation. They also found that across a dozen health behaviors there were predictable 
patterns regarding the pros and cons of progressing or digressing through the stages of 
change and noted that applied research demonstrated significant improvements in 
recruitment, retention, and progress with the use of stage-matched interventions and 
proactive recruitment procedures.  
The most dramatic results reported were achieved using computer-based 
individualized and interactive interventions (Prochaska & Velicer, 1997) and 
personalized counselors. The final and most promising finding, however, was that there 
was a strong similarity with respect to stage-matched programs between those who were 
reactively recruited who reached out to the researchers for help and those who were 
proactively recruited the researchers contacted. Prochaska & Velicer concluded that if 
similar stage-matched results continued to be encountered, programs to promote health 




While the application of the TTM to prostate screening is still under investigation, 
components of other models such as the health belief model and the theory of planned 
behavior have also demonstrated modest success in predicting participation in prostate 
cancer screening but have performed poorly in predicting which men would actively 
request the PSA test (Weinrich 2004). With lack of successful application of previously 
tested models and the successful use of the TTM in predicting breast cancer screening, 
application of the TTM to prostate cancer screening is warranted (Sheehan, 2009). 
Decision Aids 
The purpose of decision aids is to help health practitioners engage patients in 
making decisions about their treatment and screening. The Agency for Healthcare 
Research and Quality defined a decision aid as “an intervention designed primarily to 
help patients (or patients and clinicians together) with making cancer-related health care 
decisions when options are available for prevention, screening, and treatment. At a 
minimum, it should target some component of decision making” (as cited in O’Connor, 
1999, p. 67). Decision aids are used to improve patient knowledge and to foster 
communication between patients and caregivers. Elwyn (2006) found that decision aids 
are better for improving patient knowledge regarding an issue than is counseling and can 
have a strong influence on patient choice. 
There is agreement among experts who make decisions regarding the goal of 
decision aids: The aids can increase informed decision making regarding sensitive 
preferences (Nelson, Han, Fagerlin, Stefanek, & Ubel, 2007); however, experts did not 




aids. In a recent meta-analysis, Schapira (2000) found decision aids to consistently 
increase knowledge but to be less likely to affect decisions about a health care 
intervention. Schapira also noted that the main goal of increased knowledge is not truly 
obtainable on a continuous basis because increased knowledge is not always put to its 
optimal use. Schapira also noted that research has indicated that reduced numeracy, bias 
regarding information, and reasoning linked to heuristics could potentially influence the 
processing of information and also the making of decisions.  
In a study by Ellison et al. (2008), 87 African American men were enrolled in a 
program aimed at increasing knowledge that enhance health-seeking behaviors. One 
strategy used was decision aids, which “have been shown to significantly increase 
knowledge of prostate cancer screening, as well as create realistic expectations of risks 
and increase awareness of choices and decrease decisional conflict” (Ellison, 2008, p. 
1140). The researchers compared two web-based educational programs that were 
culturally specific to African American men.  
In a meta-analysis of clinical trials, O’Brien et al. (2009) considered the 
effectiveness of decision aids in cancer-related decisions and found they are effective in 
imparting knowledge without increasing anxiety about cancer screening. O’Brien et al. 
reviewed 34 trials, of which 22 addressed screening. In a study of 230 African American, 
Taylor et al. (2006) found significant improvement in knowledge and increased 
likelihood to have a PSA screening in those participants who received information 




decision aids among African American men and found that they had a significant effect 
on knowledge of prostate cancer screening.  
One purpose of using decision aids is to increase informed decision making 
(IDM). Rimer et al. (2004) found, though, that IDM can result in a slight decrease in 
screening behavior. Most IDM studies have targeted European American populations. In 
a patient education program about prostate cancer, Volk et al. (2003) used an IDM 
intervention in a group of 160 men ages 45 to 70 years. After 1 year, African American 
men were more likely to have had a PSA test than were European American men. Krist et 
al. (2007) found that patients in decision-aid groups (via web-based or paper-based 
education) were more likely to answer knowledge questions correctly but less likely to be 
screened. The authors questioned the efficacy of education in shared decision making as a 
measure of increased screening behavior. 
Although it is not clear that PSA decision aids increase knowledge, they do 
increase PSA uptake (Evans, 2005). The impact of PSA decision aids on testing may also 
have implications for policy. One such consequence could be cost savings; another is 
fewer treatments such as prostatectomies. More importantly, findings derived from this 
study can be used to provide congruent screening recommendations for African 
American males with the Preventative Health Taskforce, AUA, and other medical 
organizations. Policymakers may therefore perceive value in developing and 
disseminating PSA decision aids, but more research is needed in the formal development 
and assessment of PSA decision aid quality criteria and evaluation (Evans, 2005). Earlier 




knowledge, reduce decision conflict, provide more real expectations, and limit the 
proportion of patients that have been found to have a passive role in their decisions 
(O’Connor, 2003).  
Methodology Discussion 
 Stone et al. (2002) investigated methods used to increase preventative care 
behavior such as cancer screening in a study of 552 abstracts and articles on the topic. 
They found that 108 such studies met their requirements of controlled trials that analyzed 
increased use of cancer screening. Of the 108 studies, 81 matched a care-and-control 
group model. According to Stone et al., the most effective form of intervention was 
organizational change, which included use of different clinics designed to increase 
prevention. The second most-effective methodology was patient education, followed by 
reminders and patient feedback. I used educational interventions and a controlled 
randomized sampling method, which was also found to be a significant means of 
improving cancer screening.  
Another example of a randomized controlled trial was conducted by McPhee et al. 
(1989), which used screening reminders and educational interventions similar to Stone et 
al. (2002) to analyze the increased screening behavior of African Americans. McPhee et 
al. compared using educational interventions such as sending patients literature on 
overdue tests with reminders and no intervention. The researchers randomly assigned 180 
participants into control and experimental groups and found, unlike Stone et al. (2002), 




Shapira and Vanruiswyk (1999) examined the impact of prostate cancer screening 
aids on patients’ beliefs, knowledge, and use of prostate cancer screening tests. They also 
used controlled randomized sampling to identify 257 men from Milwaukee, Wisconsin. 
Using pamphlets as aids for increasing knowledge was effective (91% awareness 
compared with 65% awareness was found to be significant at the 0.01 alpha level); 
however, there was no significant difference in the use of prostate cancer screening tests. 
The use of the tests was found to be 82% compared with 84% and was determined to not 
be statistically significant at the 0.05 alpha level. My study adapted the above noted and 
validated methodologies by using an experimental controlled and randomized sampling 
method and active educational interventions to learn the impact of the educational 
intervention with the population.  
Data Analysis 
All statistical analyses were performed with PASW 18.0 (formerly SPSS) for 
Windows. Hypothesis 1 was tested using a two-sample t test to compare the average 
change (from pre- to postintervention) in PCK scores between the experimental and 
control groups (Ellison, 2008; Gattellari et al., 2005; Weinrich, 2007). If there were 
statistically significant differences between the experimental and control groups with 
respect to age, education level, income, insurance status, or stage of change, then analysis 
of covariance (ANCOVA) was used instead of a two-sample t test to control for those 
variables (Ellison, 2008). Hypotheses 2 and 3 were tested using a chi-square test (Ellison, 
2008; Weinrich, 2007). Collection of personal information was limited to information 




and with the data collection vendor, who signed a confidentiality agreement. Only my 
Walden University advisor and I have access to the data, which I will keep for 5 years 




Exploration of the Dependent Variables 
Knowledge of prostate cancer screening is the most common outcome measured 
in studies of prostate cancer, and both single- and multiple-item scales have been used 
(Radosevich, Partin, & Nugent, 2004). It was also found that participants who had been 
provided with decision aids knew more than the control group. Volk et al. (2003) also 
found that there was a reduction in knowledge of participants who received a decision aid 
12 months after the intervention, and that this reduction was similar to the control group. 
Frosch et al. (2003) also found that there were no significant differences in measures of 
knowledge of those who were provided with a video and those who used an aid over the 
Internet despite the fact that the proportion of participants that viewed the video was 
larger than the group that had access to the Internet aid. The trials by Gattellari et al. 
(2005) and Taylor et al. (2006) indicated increased knowledge of those who were 
provided with a printed guide instead of a video.  
The interest in screening or intent to be screened was examined through several 
studies: Volk (2003), Ruthman (2004), and Gattellari (2005). These researchers used 
Likert scales in addition to as yes and no choices. The intent to be screened was reduced 
in those who had decision aids, findings supported by Partin (2004) and Flood (1996). 
The rates of screening for PSA for the group that used the decision aids were measured 
following the receipt of those aids. There were also differences in the time of follow up 
that ranged from directly following the visit to the office to 48 hours or even up to 12 
months from receiving the decision aid (Partin, 2004; Volk, 2003; Wilt, 2001). Because 




those where participants went to the clinic on their own and where they had been 
recruited from outpatient facilities for the previous 12 months (Myers, 2005). It was 
found that there was a difference in the low portion of the screening rates but not among 
the high rates. Specifically, the low for the patients who received a decision aid was 
11.7% compared with 98.4% (in the scheduled visit study and free screening study 
respectively). In terms of the control group, the range was from 21% to 100% (Flood, 
1996).  
It was found that when screening data were examined where patients were 
recruited from offices that had their visits regularly scheduled, the RR ratio was found to 
be only 0.88%. This indicated that participants who were given decision aids had a lower 
probability of being screened compared with patients who did not. Further, Davidson et 
al. (1999) concluded that participants who were provided with aids were encouraged to 
talk about screening with their physicians, a factor that could have increased screening 
rates (O’Conner, 2003). In a study by Partin et al. (2004), there was no significant 
difference in rates of screening, which could have been attributed to the fact that 
approximately 50% of the patients had viewed the decision aid. It was also found by 
Myers et al. (2005) that screening rates as a whole were less than 10% because the aid 
was not provided prior to visiting the office. The impact of these aids on screening was 
still found to be statistically significant, with an RR ratio of 0.92, suggesting that those 





Among studies that looked into African American screening behaviors, Myers et 
al. (2005) indicated that rates of screening among this population were lower than among 
those who watched an educational video. Myers et al. also found that in patients that 
exhibited high risks, there can be an increased awareness of the risk that prostate cancer 
poses. Further, it was found that these could push some participants to be screened; 
however, Myers et al. noted that more studies were required to ascertain if screening aids 
actually result in patient empowerment and improved outcomes.  
Using the Internet for Health Information 
Dickerson et al. (2006) determined that 93 million American Internet users (80%) 
have searched the Internet for health information. Baker et al. (2003) surveyed more than 
60,000 households and received 4,764 responses, of which 40% indicated this type of 
Internet use, while a smaller percentage had used e-mail to correspond with a health 
professional. Hesse et al. (2005) found that 63% of adults had accessed the Internet for 
health information. When participants were asked whether they would go to their 
physician or to the Internet first for information, the answer was age dependent. Persons 
65 years and older were almost 10 times more likely to go to health care providers before 
using the Internet (75.6% vs. 7.7%), whereas persons 18-34 years or 35-64 years were 
almost equally split between health care providers at 38.9%) and the Internet at 46.6% 
(Hesse et al., 2005, p. 2621).  
According to the Health Information National Trends Survey (HINTS), 60.5% of 
African American adults over 18 years have used the Internet to search for health 




survey said they preferred to get their health information from a physician, only 10.9% 
typically seek information from a physician first (Hesse et al., 2005). Krist et al. (2007) 
found no differences in shared decision making between patients who received a web-
based intervention compared to those who received a paper-based intervention. 
According to Ellison (2008), web-based decision aids have two advantages: “The 
decision aid can be viewed before health appointments with variations in time to review 
and absorb the content based on individual ability, and technological advances in prostate 
cancer screening can be quickly updated and disseminated” (p. 1140). 
Prostate Cancer Knowledge Questionnaire (PCKQ) 
The PCKQ (Appendix F) measures knowledge of limitations, symptoms, risk 
factors, and side effects of prostate cancer (Weinrich et al., 2007). The instrument is 
composed of 12 yes/no /don’t know questions. The scores range from 0 to 12 where 
scores closer to 12 indicate increased knowledge. Weinrich et al. (2004) indicated that 
there was good reliability and validity for this instrument. Specifically, the Cronbach’s 
alpha of 0.77 and the theta reliability of 0.61 indicated good internal consistency and 
reliability. The content validity was provided through the review of five professionals in 
the cancer field. The construct validity was examined through a factor analysis, and each 
of the items was kept that had a factor loading of 0.35 or greater. The items were found to 
align on one factor, which provided evidence for a one dimensional scale.  
The PCKQ has also been validated with respect to African Americans and their 
knowledge of prostate cancer with respect to screening behaviors. Weinrich, Weinrich, 




instrument resulted in higher participation in screenings. The authors used a quasi-
experimental design and the PRECEDE framework to test 319 males, of which 82% were 
African American. The participants’ knowledge was measured using the PCKQ prior to 
the administration of a community-based educational program following which the 
participants were referred to their personal physicians for a free prostate cancer 
screening. The findings indicated that increased PCK predicted participation in screening 
at an alpha level of 0.05. One implication of their study using the same instrument was 
that there is a need for educational interventions among African American males to 
significantly reduce mortality rates.  
Summary 
In this chapter, I reviewed the relevant literature on the effects of a web-based 
decision aid on the knowledge and behavior of African American men regarding prostate 
cancer screening. This chapter also included a discussion of prostate cancer and prostate 
cancer screening, decision aids, and using the Internet for health information. Chapter 3 
provides the methods, research design, population and sample, instrumentation, data 




Chapter 3: Research Method 
This study tested the effects of a web-based decision aid on the knowledge and 
behavior of African American men regarding prostate cancer screening. The study was 
based on the TTM, which assesses people’s readiness to adopt new behaviors. Each 
decision aid was created to increase the participants’ awareness of prostate cancer 
prevalence, morbidity, and mortality, as well as screening and treatment options, and to 
explain the benefits and risks of prostate cancer screening. This chapter includes the 
study methods, including research design, population and sample, instrumentation, data 
collection and analysis, and steps taken for the ethical protection of participants. 
Research Design and Approach 
A quasi-experimental design was determined appropriate for this study since it 
enables the collection of data from a large number of human participants fitting a specific 
demographic or attitudinal profile. A sample size of at least 50 was deemed necessary to 
ensure that differences and commonalities were appropriately represented, as reflected by 
the power analysis conducted using G*Power (Faul, Erdfelder, Buchner, & Lang, 2009). 
See Appendix A. An experimental design allows a researcher to observe differences in 
participants’ performance and infer quasi-causal differences. This research approach also 
enables a single researcher with limited resources to collect and analyze data from a 
sample in a comparatively short time. 
Population and Sample 
The population studied was African American men ages 40-65 years. Access to 




agreed to receive e-mail from the database manager, Niche Marketing. From this 
population, a sample of 625 was randomly selected. Those who responded and agreed to 
participate had their names and e-mail addresses entered into an Excel spreadsheet. A 
unique identification number was assigned for each name, and Excel’s rand() function 
was used to insert a random number in each row of the spreadsheet. Participants were 
sorted randomly: The first 75 rows were assigned to the experimental group, and the rest 
to the control group. 
To participate, individuals had to have access to e-mail and a willingness to 
complete all study requirements. An invitation to participate was sent to all selected. 
Before the experiment, it was not known how many would meet eligibility requirements. 
Given that typical response rates to surveys are approximately 24% (Duffy, 2002), it was 
anticipated that a sample size of at least 134 was achievable, with 67 assigned to the 
experimental group and 67 to the control group.  
Plugging in a sample size of 67 for the experimental group and 67 for the control 
group indicates the study would have 80% power at the 0.05 level of significance to 
detect an effect size of 0.25 (i.e., a difference of 75% versus 53% between the 
experimental and control groups). Per G Power Analysis, a sample size of 167, then, was 
justifiable for detecting a small effect size for this study. 
Frosch (2003) found significantly lower prostate knowledge scores among those 
who reviewed a website related to prostate cancer compared to a group that used a 
traditional decision aid. “Knowledge scores were lowest for those assigned to public Web 




decision aid (8.65 [0.18] of questions correct; p = .005) ” (Frosch et al., 2008, p. 363 ). It 
appears the author misreported the standard deviations because these results would reflect 
an effect size of d = 6.27. According to Cohen (1988), small, medium, and large effect 
sizes for a two-sample t test are d = 0.2, d = 0.5, and d = 0.8, respectively. It is likely that 
Frosch actually reported the standard error of the mean rather than the standard deviation. 
In that case, the standard errors can be converted to standard deviations by multiplying 
the standard errors by the square root of the sample size. The square root of 611 is 24.72. 
If in fact Frosch actually reported standard errors, then the standard deviation would be 
approximately 0.185 x 24.72 = 4.57. This seems like a more plausible value for the 
standard deviation. If the standard deviation of the PCK score was 4.57, then the effect 
size would be (8.65 - 7.49)/4.57 = 1.16/4.57 = 0.25, which would be a small effect size 
and consistent with what one would expect given a p value of 0.005, a sample size of 
611, and a difference in means of 8.65 versus 7.49. Based on the Frosch study, it was 
reasonable to anticipate that this study would also reveal small effect sizes. For that 
reason, the sample size was determined based on the goal of detecting small effect sizes 
with 80% power and an alpha level of 0.05. 
Instrumentation 
Three surveys were used to gather data about prostate knowledge, intent to screen, 
screening behavior, and basic demographic information. A survey “is a system for 
collecting information from people to describe, compare, or explain their knowledge, 




for collecting data because they can be effectively and reliably conducted within a 
relatively short period of time.  
The study protocol required that participants complete the PCKQ and 
demographic survey prior to the web-based intervention. These instruments were 
developed by Weinrich (2006) and have been tested and used in several studies. Weinrich 
released the PCKQ and demographic survey for public use for research in 1998 and gave 
me permission to use it in this study (Appendix B). This survey has been previously 
tested with African American men (Weinrich, 2004). The survey was content-validated 
by three subject matter experts (SMEs) and is assumed to reliably measure PCK. The 
demographic survey contained one question to assess participants’ stage of change. The 
intervention group viewed Website A, CDC Prostate Cancer Screening: A Decision 
Guide for African Americans. The control group viewed Website B, What You Need To 
Know About Prostate Cancer. Website A contained a prostate cancer screening decision 
guide for African Americans developed by the Centers for Disease Control and 
Prevention (CDC). This booklet covered understanding the prostate, risk factors, 
symptoms, detection, testing, and the pros and cons of treatment. This decision aid was 
used by Weinrich et al. and other researchers in similar community-based prostate 
educational programs and was designed for and tested with African American men.  
 Website B contained a prostate cancer screening decision guide developed by the 
National Cancer Institute (NCI–NIH Publication No. 08-1576). This booklet covers 
topics including understanding the prostate, risk factors, symptoms, detection, diagnosis 




contained a list of questions to promote discussion and informed decision making with a 
person’s primary care physician, but it was not designed for the culture of African 
American men. Directly after viewing the web-based prostate screening intervention on 
Website A or B, the participants completed the PCKQ to measure knowledge change and 
the IST. These surveys addressed limitations, symptoms, risk factors, side effects from 
treatment, and screening age guidelines. The PCKQ had 12 questions, answered either 
true, false, or don’t know. The IST had one question and took about 1 minute to answer. 
The one question on the IST was submitted to participants directly after the web-based 
intervention. Two weeks after intervention, participants received a final survey question 
to assess actual screening behavior change.  
Because no published studies have used the transtheorical stages of change model 
in prostate cancer screening interventions, I decided to evaluate stage of change in 
relation to the dependent variables PCK, intent to screen, and screening behavior. In 
other studies, the measure stages of change has shown high reliability and stability 
(Morera et al., 1998) and high predictive and construct validity (Crittenden, Manfredi, 
Warnecke, Cho, & Parsons, 1998).  
To assess stage of change, a single question used in colon rectal screenings was 
added to the demographic survey. In a single-question algorithm, each response option 
indicates one definite stage, and respondents must classify themselves (Courneya, 1995; 
Haire-Joshu et al., 1999). Stage of change refers to a participant’s readiness to adopt a 
healthy behavior, such as prostate cancer screening participation (Spencer, Pagell, & 




best describes their current level of interest in prostate cancer screening (DRE or PSA 
blood test). The response options and corresponding stages were as follows:  
1. Precontemplation: I have never had a DRE or PSA and I do not plan to have 
one.  
2. Relapse: I have had at least one DRE or PSA in the past, but I am now off 
schedule and do not plan to have a DRE or PSA.  
3. Contemplation: I have never had a DRE/or PSA, but I plan to have one or I am 
off schedule after having a prior DRE or PSA but I intend to have one.  
4. Action: I have had one DRE or PSA on schedule and I intend to have another 
as scheduled.  
5. Maintenance: I have had at least two DREs /or PSAs on schedule, and I intend 
to have another in a time frame that will keep me on schedule. 
The reliability and validity of the survey were noted in studies that used methods 
similar to this study. The reported internal consistency (0.77), and the reliability that the 
knowledge score displayed (0.61) were indications of that finding (Weinrich, 2004). In 
addition, the finding of content validity was met with agreement by health professionals 
who specialized in cancer. Finally, the construct validity was calculated through a factor 
analysis where every item was kept that had a corresponding factor value over 0.35. The 
final 12 items that remained that clustered on one specific factor showed that the scale 
was one dimensional.  
The IST (Appendix C) contains one yes-no question: “Now that you have 




appointment for a PSA or DRE prostate cancer screening?” The screening behavior 
survey (Appendix D) was sent to participants 2 weeks after they reviewed the prostate 
health information website. It contained one yes-no question: “Two weeks have passed 
since you reviewed the prostate health information website. Have you scheduled or had a 
PSA or DRE screening?” Reliability and validity are psychometric properties of 
instruments designed to measure psycho-social-behavioral constructs. The two yes/no 
questions on my survey (Appendices C and D) were factual questions and, therefore, 
reliability and validity did not apply. In addition, reliability and validity did not apply to 
demographic questions because those were factual also. 
The demographic survey (Appendix E) is an eight-item survey that asks 
participants about age, gender, ethnicity, education, income, and insurance status. It took 
about 2 minutes to complete. These questions were used to provide descriptive statistics 
about the participant pool and to screen participants who do not meet the three study 
criteria: African American descent, age 40-65 years, and no diagnosis of prostate cancer. 
Internal validity is defined as how confidently one can conclude that the change in 
the dependent variable was produced solely by the independent variable and not 
extraneous ones (Campbell & Stanley, 1966). There are eight empirically identified 
conditions that can threaten confidence in a study: history, maturation, testing, 
instrumentation, statistical regression, selection, experimental mortality, and selection 
interaction. The two most likely threats to internal validity in the study were selection and 
testing. A selection threat suggests that participants may not be functionally equivalent at 




was sufficient for the study and statistical techniques used. A testing threat entails testing 
participants at different times or under different circumstances. I tested all participants 
within a short time frame, which reduced the number of extraneous factors that could 
potentially influence responses. 
External validity is defined as the extent to which results can be generalized. 
Studies that employ randomization to select participants have more external validity than 
those that do not. This study used convenience sampling, which can weaken external 
validity. This was used because random sampling of the entire population is not possible. 
Although the convenience samples were separated into two groups, some weakening of 
external validity could have occurred, and results may not reflect attitudes of the larger 
population.  
Data Collection 
Participants were sent an e-mail reminding them of the purpose of the study and 
informing them of their ID number. The email discussed voluntary participation and 
withdrawal along with providing an opportunity to acknowledge their interest in 
participation. This message instructed them to enter their ID when they took the online 
survey. At the end of the message was a hyperlink that directed them to the survey site. 
The first page of the survey was an informed consent form, at the bottom of which was a 
button that said, “By clicking here, you are providing informed consent.” Approximately 
14 days after the first follow-up data were collected, a second e-mail asked if they had 




After I completed baseline data collection, I downloaded the data from the 
Zoomerang.com website into an Excel spreadsheet and organized it by group. When the 
second follow-up data collection was completed, those data were downloaded from the 
Zoomerang.com website into a second Excel spreadsheet. Using Microsoft Access, I 
merged the spreadsheets, then exported back into an Excel spreadsheet. In this way, each 
participant was represented as one row in the spreadsheet, with corresponding 
demographic data, baseline knowledge data, and follow-up data displayed in columns. 
When the final follow-up data were collected, an additional column was added to the 
Excel data file. Finally, the Excel file was imported into PASW software for analysis. 
Data Analysis 
All statistical analyses were performed with PASW 18.0 (formerly SPSS) for 
Windows and EpiInfo 7. All analyses were two-sided with a 5% alpha level. 
Demographic characteristics of the study sample were described using the mean, standard 
deviation, range for continuous scaled variables, and frequency and percent for 
categorical scaled variables. 
Although participants were assigned to either the experimental or control group, 
there were differences between the two groups with respect to age, education level, 
income, and insurance status. To determine if group assignments produced similar 
groups, each variable was statistically compared between the two groups. If statistically 
significant differences were found, those variables were controlled for in the analysis. If 
the age and income distributions were roughly normal, two-sample t tests were used to 




and income were subjected to Mann-Whitney tests. Chi-square tests were used to 
compare education distribution and insurance status between the two groups. 
Operationalizing Dependent and Independent Variables 
Data analysis for the study was based on one independent variable (treatment 
group) and three dependent variables (PCK, intent to screen, and screening behavior). 
These variables and the techniques that were used to analyze them are described below. 
Independent Variable 
Treatment group (TG) was measured on a categorical scale with two categories: 0 
= control group, and 1 = experimental group. The experimental group viewed Website A, 
and the control group viewed Website B. 
The following describes the measurements: 
1. Age was measured in years on a continuous measurement scale. 
2. Education level was measured on a categorical measurement scale. A 
participant’s education level was recorded as 0 = no high school diploma or 
GED; 1 = high school or GED; 2 = some college; 3 = associate’s degree; 4 = 
bachelor’s degree; 5 = master’s degree; or 6 = doctorate degree. 
3. Income was measured on a continuous measurement scale in U.S. dollars. 
4. Insurance status was measured on a categorical measurement scale with two 
categories: 0 = no insurance, or 1 = some insurance. 
5. Stage of change was measured on a categorical measurement scale with two 
categories: (a) 0 = I have never had a DRE or PSA, and I do not plan to have 




schedule and do not plan to have a DRE and/or PSA and (b) 1 = I have never 
had a DRE or PSA, but I plan to have one, or I am off schedule after having a 
prior DRE or PSA, but I intend to have one, or I have had one DRE or PSA on 
schedule, and I intend to have another as scheduled, or I have had at least 2 
DREs and/or PSAs on schedule. I intend to have another in a time frame that 
will keep me on schedule. 
Dependent Variables 
Prostate cancer knowledge (PCK) was measured on a continuous scale with a 
range of 0-100. Participants completed the PCKQ before and after the intervention. The 
PCK score was derived by calculating the percentage of Questions 1-12 from the survey 
that were answered correctly. “Don’t know” responses were treated as incorrect answers. 
Smaller scores indicate less knowledge of prostate cancer and larger scores indicate more 
knowledge. The difference between the post-intervention knowledge score and the pre-
intervention knowledge score (change in PCKQ) was the first dependent variable. 
Intent to screen (IS) was measured on a categorical scale with two categories. 
After reviewing the website, participants were asked if they intended to have a PSA 
screening test. This variable was derived from Question 1 on the IST. Intent to screen 
status was recorded as 0 = no intent to have a PSA screening test, or 1 = yes, intend to 
have a test. 
Screening behavior (SB) was measured on a categorical scale with two categories. 
Approximately 14 days after the intervention, participants were asked if they had had a 




Question 1 on the SB survey. Screening behavior was recorded as 0 = no if no screening 
and one not scheduled one, or 1 = yes if screened or had scheduled a test. 
Hypothesis Testing 
 Research Question 1: Do intervention groups experience a greater increase in 
prostate cancer knowledge (PCK) than those not exposed to the intervention?  
H10: There is no difference in the PCK change score between the experimental 
and control groups.  
H1a: There is a difference in the PCK change score between the experimental 
and control groups. 
 Hypothesis 1 was tested using a two-sample t test to compare the mean change 
(from pre- to postintervention) in PCK scores between the experimental and control 
groups. The change score was calculated by subtracting the pretest score from the posttest 
score, separately for each participant. When the p value resulting from the t test was less 
than 0.05, the null hypothesis was rejected, and it was concluded that the experimental 
intervention had a different effect on PCK than did the control intervention. The size and 
direction of the difference between the two groups was demonstrated by reporting the 
average change in PCK scores separately for the experimental and control groups. 
When there were statistically significant differences between the experimental 
and control groups with respect to age, education level, income, insurance status, or stage 
of change, then analysis of covariance (ANCOVA) was used instead of a two-sample t 
test to control for those variables. When the average change in the PCK score was 




null hypothesis was rejected, and it was concluded that the experimental intervention had 
a different effect on PCK than did the control intervention. The size and direction of the 
differences between the two groups was demonstrated by reporting the adjusted mean 
postintervention PCK score separately for the experimental and control groups. The 
adjusted means indicate the expected average PCK score, assuming the two groups were 
equal with respect to the covariates. 
 Research Question 2: Do participants in the intervention group have a higher 
intent to screen (IS) score than those not exposed to the intervention?  
H20: There is no difference in IS scores between the experimental and control 
groups. 
H2a: There is a difference in IS scores between the experimental and control 
groups. 
Hypothesis 2 was tested using a chi-square test. When the chi-square test was 
statistically significant, the null hypothesis was rejected, and it was concluded that the 
percentage of participants who intend to screen was different for the experimental and 
control groups. The size of the difference between the two groups was demonstrated by 
reporting the number and percentage of participants who intend to screen separately for 
each group. When there were statistically significant differences between the 
experimental and control groups with respect to age, education level, income, or 
insurance status, those variables was controlled for using multiple linear regression 
analysis. The dependent variable was intent to screen, the independent variable was the 




variables were different between the two groups. When multiple linear regression 
analysis was warranted, the odds ratio for group was the primary focus. When the odds 
ratio for group was statistically significant, the odds ratio and 95% confidence interval for 
the odds ratio were reported and interpreted. 
 Research Question 3: Are participants in the intervention group more likely to 
schedule a PSA screening test than those in the comparison group?  
H30: There is no difference in scheduling or undergoing a PSA screening test 
between the experimental and control groups. 
H3a: There is a difference in the odds of scheduling a PSA screening test 
between the experimental and control groups. 
 Research Question 4: Are participants in the intervention group more likely to 
have a PSA screening test than those in the control group? 
H40: There is no difference in the odds of having a PSA screening test between 
the experimental and control groups. 
H4a: There is a difference in the odds of having a PSA screening test between 
the experimental and control groups. 
Hypotheses 3 and 4 were tested using a chi-square test. When the chi-square test 
was statistically significant, the null hypothesis was rejected, and it was concluded that 
the percentage of participants who either had PSA screening or scheduled one was 
different for the experimental and control groups. The size of the differences between the 
two groups was demonstrated by reporting the number and percentage of participants 




statistically significant differences between the experimental and control groups with 
respect to age, education level, income, insurance status, or stage of change, those 
variables were controlled for using multiple linear regression analysis. The dependent 
variable was knowledge change scores, the independent variable was group 
(experimental or control) and appointment. The coefficients for intervention group 
(experimental or control) and appointment were the primary focus. When the coefficients 
were statistically significant, then the effect of independent variables was said to be 
significant.  
Data Storage 
Collection of personal information was limited to information deemed essential 
for the study. All responses were stored in a secure server file at my office and with the 
data collection vendor. The data-collection firm signed a confidentiality agreement, and 
only my Walden advisor and I have access to the data. Data will be kept for 5 years after 
completion of the study and will then be destroyed.  
Protection of Human Subjects 
This study was conducted in accordance with Walden University’s Institutional 
Review Board (IRB) research protocols, recognizing that students acting as researchers 
are held accountable for their ethics. One stipulation is that researchers must obtain 
informed consent from all participants (Gall, Borg, & Gall, 2002). Elements of informed 
consent include notifying participants of who will conduct the study and the time 
commitment. Informed consent also means the study has been explained in easily 




voluntary and that they can withdraw at any, and limits of confidentiality have been 
explained. Informed consent also requires that steps are taken to ensure that participants 
emerge from the research unharmed (Rudestam & Newton, 2001).  
This proposal was given approval number 02-10-11-0061692 by the Walden 
University IRB. Following approval, I made initial contact with potential participants via 
e-mail, including a description of the study’s purpose and scope, criteria for inclusion, 
and informed consent. Participants were assured they would not be identified by name in 
the presentation or dissemination of the findings and that all results would be reported as 
group data with no identifying individual information.  
Summary 
In Chapter 3, I described the method used for analyzing the data for the four 
research questions. Data analysis was based on one independent variable (treatment 
group) and three dependent variables (prostate cancer knowledge, intent to screen, and 
screening behavior). Hypotheses were tested using two-sample t tests, chi-square tests, 
ANCOVA, and multiple linear regression analysis. The results, data analysis, and 
interpretation comprise Chapter 4, and Chapter 5 will include a robust discussion of key 




Chapter 4: Results  
The purpose of this quantitative study was to investigate whether a web-based 
decision aid would increase the intention and follow through of African American males 
to seek prostate cancer screening. The chapter includes a description of the demographics 
of the participants, descriptive statistics of variables used in the study, and the results of 
the two-samples t test used to determine whether there was a significant difference 
between the PCK scores of preintervention and postintervention with the control and 
experimental groups. The results of the chi-square analysis were also used to answer 
whether the intervention affected the experimental group.  
A total of 128 men participated in the study. The control group had 48 
participants, and the intervention group had 80. Participants were randomly assigned 
either to the experimental or control group. A unique identification number was assigned 
for each name, and Excel’s rand() function was used to insert a random number in each 
row of the spreadsheet. Participants were sorted randomly, and the first 75 rows were 
assigned to the experimental group, and the rest to the control group. However, random 
assignment failed for an unknown reason. The data showed that the number of cases 
assigned to the conditions was not similar and that characteristics differed significantly 
between the groups. Dropout rates remained the same for the experimental and control 
groups, so significance testing could be performed without concern for confounding. Fair 
tests of differences in outcome variables would require complete adjustment for 
differences between groups. Consequently, the hypothesis tests were not definitive. 




scheduling and intent to screen) was small, reducing the power of the tests. Per G Power 
Analysis, a sample size of 67 in the experimental group and 67 in the control group 
would have 80% power at the 0.05 level of significance to detect an effect size of 0.25 
(i.e., a difference of 75% versus 53% between the experimental and control groups; see 
Appendix F). I had collected data for 9 months and exhausted the entire database and all 
appropriate contacts resulting in 128 participants. Moreover, the number of 14-day 
follow-up respondents was very low. The closest to a fair test of the hypotheses were the 
multiple linear regressions that were run using knowledge change score as the dependent 
variable and appointment and intervention group as the independent variables. I have 
determined that the randomization failure was due to my error while using the Excel’s 
rand() function. After re-examination of the data set, it appears that I sorted on the wrong 
column. I should have sorted on column A which contained the database email addresses 
verses column B which contained the rand() number. To prevent this error in the future, 
it is better to sort using the Excel Advanced Filter function.  
The following research questions and hypotheses were postulated to guide this 
study:  
 Research Question 1: Do intervention groups experience a greater increase in 
prostate cancer knowledge (PCK) than those not exposed to the intervention?  
H10: There is no difference in the PCK change score between the experimental 
and control groups.  
H1a: There is a difference in the PCK change score between the experimental 




 Research Question 2: Do participants in the intervention group have a higher 
intent to screen (IS) score than those not exposed to the intervention?  
H20: There is no difference in IS scores between the experimental and control 
groups. 
H2a: There is a difference in IS scores between the experimental and control 
groups. 
 Research Question 3: Are participants in the intervention group more likely to 
schedule a PSA screening test than those in the comparison group?  
H30: There is no difference in scheduling a PSA screening test between the 
experimental and control groups. 
H3a: There is a difference in scheduling a PSA screening test between the 
experimental and control groups. 
 Research Question 4: Are participants in the intervention group more likely to 
have a PSA screening test than those in the comparison group? 
H40: There is no difference in the odds of having a PSA screening test between 
the intervention and control groups. 
H4a: There is a difference in the odds of having a PSA screening test between 
the intervention and control groups. 
Descriptive Frequency of the Study Variables 
Table 1 shows the demographic attributes of the participants. It was found that 
more held college degrees than is found in the general population of the demographic or 




randomly selected by Niche Marketing were atypical of their ethnic group, gender, and 
nationality. In fact, the reported annual salaries of nearly one third ranged from $50,000 
to $100,000, which is much higher than average for the United States. Since 96.9% of 
them are undiagnosed with prostate cancer, that condition may have accounted for 61% 
stating they had scheduled an appointment for PSA or DRE prostate cancer screening 
after the study ended. Most participants have some insurance (92.2%), although few were 
eligible for Medicare. Again, this is not representative of Americans in general. Over 
90% expressed an interest in prostate cancer screening, but most had not scheduled the 
screening. Too few responded to the follow-up survey to determine if they had scheduled 




Table 1  
  









No HS diploma 7 5.5 
High school 12 9.4 
Some college 36 28.1 
Bachelor's degree 27 21.1 
Master's degree 46 35.9 
Age 
40 and below 15 11.9 
41 – 45 23 17.9 
46 – 50 32 24.9 
51 – 55 29 22.6 
56 – 60 12 9.4 
61 – 65 17 13.4 
Income 
$49,999 and less 33 26.4 
50,000 to 99,999 39 31.2 
100,000 to 149,999 27 21.7 
150,000 to 199,999 11 8.8 
200,000 to 249,999 8 6.4 
250,000 to 299,999 5 5.0 
300,000 and up 1 0.8 
Total 124 100.0 
Appointment 
Yes 78 60.9 
No 50 39.1 
DX 
Yes 4 3.1 
No 124 96.9 
Insurance 
None 9 7.0 
Some 118 92.2 
Missing 1 0.8 
Interest 
None 11 8.6 
Some 117 91.4 
Scheduled in 2 
weeks 
Yes 23 37.7 
No 38 62.3 
Total 61 100.0 





 An analysis of variance determined whether there was a significant difference in 
the postintervention PCK scores between the experimental and control groups while 
controlling for preintervention PCK scores. Based on the results shown in Table 2, it can 
be seen that there is no significant difference between experimental and control groups 
with respect to the age, education level, income, insurance status, and stage of change. 
Therefore, a two-samples t test was conducted to check if there was a significant 
difference between the average change (from pre- to postintervention) in PCK scores 
between the experimental and control groups. Based on the results shown in Table 3, 
there was a significant change in those scores ( p value = .001) who underwent the 
intervention. Table 4 shows that Website A (intervention group) had a statistically higher 
mean score difference (M = 2.4222) than that of Website B (control group; M = .163). 
This also means that the participants who underwent the intervention learned more about 
prostate cancer. Thus, the alternate hypothesis was tentatively accepted, pending an 
examination of the possible effects of covariates.  
Table 2 
Analysis of Variance Between Groups and Demographics 
 Df F Sig. 
Age 5 .862 .508 
Income 6 .233 .965 
Education 4 1.573 .185 
Insurance 2 .346 .708 





Two-Sample t Test Group Statistics Results 





CDC 80 2.4222 3.66268 .38608 
NIH 48 .1633 3.95994 .56571 
 
Table 4 
Two Samples t Test Between Changes in PCK Scores 
  
Levene's test 
for equality of 
variances 
t test for equality of means 

















  3.298 92.325 .001 2.25896 .68489 
 
 In addition to the ANOVA, I conducted a series of interaction tests to examine the 
relationship of the demographic variables to the intervention group. Based on the results 
shown in Table 5, all variables have a significant relationship to the intervention 
(education = .017, age = .001, income = .007, appointment = .001, and insurance = 
.002). This means that the PCK scores had significant effects based on the intervention 
group and with respect to the demographics of participants. The interaction test between 
the covariates and intervention group showed the demographic variables to be significant 





Interaction Test Between Intervention Groups, Demographics, and Difference of Scores 
Source Df Mean squares F Sig. 
Intervention group * education 2 63.018 4.187 .017 
Intervention group * age 2 109.180 7.611 .001 
Intervention group * income 2 76.764 5.173 .007 
Intervention group * appointment 2 113.373 7.939 .001 
Intervention group * insurance 2 97.137 6.686 .002 
  
 I conducted a chi-square goodness of fit to test whether there was a significant 
difference in the intent to screen between the experimental and control groups. After the 
participants had reviewed the prostate cancer health information website, they were asked 
if they would be scheduling an appointment for a PSA or DRE prostate cancer screening. 
The results shown in Table 6 indicate no significant difference between the intent 
to screen of those in the experimental group and those who are in the control group 
(Pearson’s Chi-square p value = .229). This means that the results of the intention of a 
participant do not vary based on their intervention group. In this case, the experimental 
group’s intention to screen for prostate cancer does not vary even though participants 
have more knowledge about prostate cancer than those in the control group. Table 7 
shows that the intervention group with respect to the intention to screen for prostate 
cancer had a significant effect on the difference of PCK scores (p value = .020). This 
means that their perspectives on PSA screening for prostate cancer changed based on the 
information they obtained through this study. However, based on Table 8, there are no 




screen. This means that the demographic variables cannot predict the intention of a 
participant to screen for PSA.  
Table 6 
Chi-Square Goodness of Fit (Intent To Screen) 









 1 .229   
Continuity correction 
b
 .331 1 .565   
Likelihood ratio 2.346 1 .126   
Fisher's exact test    .550 .311 
Linear-by-linear 
association 
1.433 1 .231   
 
N of valid cases 122. 
Note. 
a
 2 cells (50.0%) have expected count less than 5. The minimum expected count is 
.96. 
b
 Computed only for a 2x2 table. 
 
Table 7 
Interaction Test Between Intervention Groups, Demographics, and Intent to Screen 
Source Df Mean Square F Sig. 
Corrected model 2 28.129 4.069 .020 
Intercept 1 70.539 10.204 .002 






Results of Logistic Regression (Intent To Screen) 
 B S.E. Wald df Sig. 
Education -8.908E-02 .159 .312 1 .576 
Age .041 .155 .069 1 .793 
Income -8.370E-02 .182 .211 1 .646 
Appointment -4.944E-01 .508 .949 1 .330 
Insurance -1.459E-01 1.015 .021 1 .886 
Intention -2.063E+01 28292.943 5.319E-07 1 .999 
Constant 21.049 28292.943 5.535E-07 1 .999 
 
 To test whether there was a significant difference in scheduling a PSA screening 
test between the experimental and control group, I conducted another chi-square 
goodness of fit. Fourteen days after the participants had taken the PCK survey, they 
completed a screening behavior survey about their scheduling an appointment for PSA or 
DRE screening. Based on the results shown in Table 9, it can be seen that there are no 
significant difference in scheduling or undergoing a PSA screening test between the 
experimental and control groups (Pearson’s Chi-square = .298). This means that the 
perceptions of a participant scheduling a PSA appointment did not change even after he 
had more knowledge about prostate cancer through reviewing the prostate health 
information website. Based on the results shown in Table 10, it can be observed that there 
are no significant effects on the decision of the participants to schedule (p value = .439) 
an appointment for PSA. This means that the participants’ decision to schedule for a PSA 
appointment does not depend on the intervention group, and it does not affect the 




(Table 11) showed that there are also no significant differences found in the demographic 
variables with respect to the screening behavior of the participants. This means that none 
of the demographic variables predicted the decision to schedule for a PSA appointment.  
Table 9 
Chi-Square Goodness of Fit (Making an Appointment) 









 1 .298   
Continuity correction 
b
 .530 1 .467   
Likelihood ratio 1.060 1 .303   
Fisher’s exact test    .357 .232 
Linear-by-linear 
association 
1.065 1 .302 
  
N of valid cases 63     
Note. a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is 
5.33. 
b. Computed only for a 2x2 table. 
 
Table 10 
Interaction Test Between Intervention Groups, Demographics, and Screening Behavior 
Source Df Mean Square F Sig. 
Corrected model 2 6.002 .835 .439 
Intercept 1 33.014 4.593 .036 





Results for Logistic Regression (Screening Behavior) 
 B S.E. Wald df Sig. 
Education -.545 .316 2.963 1 .085 
Age -.385 .304 1.601 1 .206 
Income .632 .324 3.796 1 .051 
Appointment -.848 .847 1.002 1 .317 
Insurance -.003 2.552 .000 1 .999 
Scheduled 2 weeks -.484 .697 .481 1 .488 
Constant 1.915 3.544 .292 1 .589 
 
A multiple linear regression was conducted to assess if intervention group and 
appointment predicts the knowledge change scores. The results of the multiple linear 
regression were significant, F (2, 115) = 5.32, p = .006, suggesting that intervention 
group and appointment accounts for 8% of the variance in knowledge change scores. 
Further exploration revealed that intervention group was a significant predictor of 
knowledge change scores, B = -1.13, p = .023, suggesting that participants in the 
intervention group had knowledge change scores that were 1.13 points less than the 
nonintervention group. The appointment also significantly predicted knowledge change 
scores, B = 1.05, p = .031, suggesting that those who had appointments had knowledge 
change scores increased by 1.05 points. Results of the multiple linear regression are 






Multiple Regression With Intervention Group and Appointment Predicting Knowledge 
Change Score 
 
Source B SE F p 
Intervention group -1.13 0.50 5.32 .023 
Appointment 1.05 0.48 4.76 .031 
 
 A multiple linear regression was also conducted to assess if intervention group, 
appointment, and the interaction predicts the knowledge change scores. The results of the 
multiple linear were significant, F (3, 114) = 3.83, p = .012, suggesting that intervention 
group and appointment accounts for (R
2
) 9% of the variance in knowledge change scores. 
Further exploration revealed that intervention group was a significant predictor of 
knowledge change scores, B = -1.50, p = .019, suggesting that participants in the 
intervention group had knowledge change scores that were 1.50 points less than the 
nonintervention group. Results of the multiple linear regression are presented in Table 13. 
Table 13 
 
Multiple Regression With Intervention Group, Appointment, and the Interaction 
Predicting Knowledge Change Score 
 
Source B SE F p 
Intervention group -1.50 0.63 5.66 .019 
Appointment -0.22 1.45 0.03 .879 






 In this chapter, I discussed whether there was a significant difference between the 
experimental and control group based on the PCK scores, intent to screen, and screening 
behavior. The study aimed to determine whether there is a significant difference between 
the behavior of the participants in the experimental and control group. In order to 
determine this, analysis of covariance and a series of chi-square goodness-of-fit analysis 
were conducted.  
 The first ANOVA determined that there is no significant difference in the PCK 
scores between the experimental and control group while controlling the preintervention 
PCK scores and the demographics of the participants. However, based on the succeeding 
analysis, it was shown that there is an evident change in the scores of the participants 
based on the intervention they went through. The CDC group, which is the experimental 
group, has higher mean scores than the control group. This means that there is an increase 
in the PCK of the participants who underwent the intervention than the participants in the 
control group. There were also positive interactions between the demographic variables 
and the intervention group. This means that the demographic variables are statistically 
significant to know the effect of the intervention in the current study. This also means 
that based on the difference of the scores yielded in the study there are significant 
differences in the scores of the experimental group. Thus, the alternate hypothesis cannot 
be accepted because the mean difference in outcome knowledge might have been caused 




 Moreover, for Hypothesis 2, I conducted a chi-square goodness of fit analysis to 
investigate the difference in the intent to screen between the experimental and control 
groups. It was determined that there is no significant difference between participants’ 
attitudes with regard to screening for prostate cancer. This means that the participants’ 
intention to take a screening test for prostate cancer does not vary based on the 
intervention taken during the study. An interaction test was conducted to examine the 
intervention on whether there is an effect to the intention of the participants to be 
screened for prostate cancer. It yielded a positive result, which means that the variables 
presented in the study had a significant effect on the intention to be screened. 
Furthermore, logistic regression indicated these variables cannot predict their 
participants’ decision with regard to screening. This indicates that the null hypothesis 
might be accepted. However, the number of cases available was small, and covariates 
could not be controlled, so this null result might have been an artifact of low power. 
 For the third hypothesis, I conducted another chi-square goodness-of-fit analysis 
to determine if there were any differences in decisions of participants to schedule an 
appointment in PSA based on knowledge gained through reviewing information about 
prostate cancer. There was no significant difference in the scores, meaning that even 
though they had gained more information about prostate cancer and how it can be 
prevented, it did not encourage them to schedule a PSA appointment. Another interaction 
test was conducted to examine the effect of the demographic variables to the decision of 
the participants to schedule for an appointment. There was no significant interaction 




PSA appointment. Again, the number of cases available was small, and covariates could 
not be controlled, so this null result might have been an artifact of low power. 
The fairest test of the intervention group’s impact on the participants’ knowledge 
score was the final statistical analysis, the multiple linear regression. The findings 
indicated that the intervention group had a significantly lower knowledge change score 
than the nonintervention group. In Chapter 5, I will draw conclusions from these results 




Chapter 5: Discussion, Conclusions, and Recommendations 
The purpose of this study was to test whether a web-based prostate health 
decision aid could effectively increase prostate cancer screening and informed decision 
making among African American men 40 years and older who have not been diagnosed 
with prostate cancer. I used two samples t test, chi-square analysis, analyses of variance, 
and linear regression to examine the data for both control and experimental groups. From 
the results presented in Chapter 4, I determined some implications of the findings about 
the effectiveness of the methods used to inform African American males about prostate 
cancer screening. Lack of follow-through responses from participants precluded learning 
whether they scheduled and followed through with decisions to seek or not seek 
screening  
Discussion 
Every decade, the risk for American men having prostate cancer increases, and 
the disease is now the second-leading cause of cancer deaths in the United States among 
men older than 50 years (Volk et al., 2007). As a result, studies of whether PSA is an 
accurate predictor of cancer have been of particular interest in medical research. While 
studies have found that although medical science has greatly improved prostate cancer 
detection and survival rates, there is a continuing need for health education and 
awareness to increase early detection rates and improve overall survival (Chan et al., 
2003; Jones, 2007; Woods, 2006). The study of Schapira and Van Ruiswyk (2000), who 
found that prostate cancer is a slow-progressing disease that can remain clinically 




and improved health education may help to reduce the number of men who die from 
prostate cancer.   
Frosch et al., (2003) stated that there are no differences found in the participants’ 
likelihood of scheduling a prostate cancer screening exam. However, based on that same 
study, it was found that an educational video about the risks and benefits of prostate 
cancer screening was more effective than Internet-based information. The participants in 
this study showed greater increase in the PSA knowledge but were more likely to decline 
the PSA test than those in the Internet group. Another study showed that intervention, no 
matter which method, helps in increasing cancer knowledge (Ellison et al., 2008). Most 
studies show that educational attainment, geographic location, age, and health behavior 
have a greater effect on whether a person seeks information about and acts on 
recommendations of health professionals (Partin, 2004; Volk, 2003; Wilt, 2001). 
Although the chi-square goodness-of-fit yielded no significant difference with the 
intervention group, the result is important in proving that intention for PSA screening is 
not related to the means participants used to learn about prostate cancer screening. The 
results of the analysis showed that the participants’ mean scores were not significantly 
different from the groups with respect to their intention to screen for PSA. The result 
further supported the findings of Jones (2007), who argued that reliability of the tests is a 
factor that hinders the use of PSA and DRE. Regardless of the provision of information 
that details the benefits of early detection tests for prostate cancer, there is no assurance 




I also took into account the screening behavior of the participants after the pre- 
and postsurvey questionnaires. According to the analysis, there are also no significant 
differences in the mean scores of the participants and intervention group with respect to 
their screening behavior. The decision to schedule for a PSA appointment did not vary 
based on the intervention groups. When considering interaction between the groups, 
intention to screen, and screening behavior, it was evident that the variables did not 
predict the decision or intention of the participants to screen or to schedule a PSA 
appointment. This means that even though participants found both benefits and risks from 
screening, it is likely that other concerns led them not to undergo PSA screening.  
The final analysis was a multiple linear regression where the dependent variable 
was knowledge change score and the independent variables were the intervention group 
and appointment. In the second regression, an interaction term between the two 
independent variables. The regressions were both statistically significant with F score p 
values of 0.006 and 0.012 respectively. In addition, the findings were consistent in that 
the knowledge change scores of the intervention group were less than for the 
nonintervention group. This indicates that the intervention group did worse on the 
knowledge change scores than did the nonintervention group.  
There were several desired outcomes of this study: (a) increased awareness of 
prostate cancer prevalence, morbidity, and mortality among African American men; (b). 
increased awareness in African American men regarding the etiology and risk of prostate 
cancer as well as screening and treatment options; and (c) increased rates of prostate 




understanding whether increasing awareness of prostate cancer prevalence, morbidity, 
and mortality affected intention and behavior in terms of scheduling PSA or DRE 
screening, the results were not empirically robust enough for any conclusions. The only 
significant finding was a lower knowledge change score for the experimental group than 
for the control group. The number of cases in the experimental and control groups was 
dissimilar, and characteristics between the groups also differed significantly. This 
required an adjustment for the reported differences between the two groups; however, I 
did not make that adjustment for this study. Thus, the conclusions are only valid with the 
assumption that there was no significant difference between the characteristics of the 
participants in the two groups. Further, samples of the study are relatively small to 
generate a good power of the test for two of the outcomes (appointment scheduling and 
intent to screen). 
Implications for Social Change 
Because of the number of advanced prostate cancer cases and subsequent deaths 
of African American men that is disproportionate to their numbers in the population, I 
hoped the findings might lead to more effective ways to reach and inform this population 
with health information and treatment options. Although the results were not definitive, 
the failure of many participants to either make or follow through with a medical 
appointment or complete the activities of the study points up the need for additional 
research in ways to reach this population. Because the population is both vulnerable and 
relatively uninformed—maybe by choice—there is a great need to learn methods that will 




program that convinces them of the wisdom of seeking screening should save more lives, 
and the lives of these men and their families should provide positive social change not 
only for the population they are a part of but to the medical community. 
Some publications regarding the controversy of PSA and DRE screenings have 
recommended delaying screenings since prostate cancer is slow growing and occurs late 
in life. Typically, men who develop prostate cancer die of other diseases; however, this is 
not the case for African Americans, who have a strong genetic predisposition to prostate 
cancer. Nonetheless, because they are typically diagnosed later, upon discovery, the 
disease is more advanced. Because there is no consensus in the medical community about 
the wisdom of screening, at what age, and what method to use, too few men may be 
encouraged to be proactive about their health. In fact, the AUA, AMA, and other medical 
associations do not have congruent recommendations regarding screening for 
males. Thus, without medical screening consensus and the continued proliferation of 
prostate cancer morbidity and mortality with African American males, the social change 
of increased quality and length of life will likely not be realized.  
Limitations of the Study 
 The study is not generalizable to all African Americans in the United States. 
Although 180 participants were identified and began the activities, many failed to 
complete the activities, leaving only 80 participants for the CDC group and 48 for the 
NIH group. Analysis was also only of the relationships of the known variables based 




 The second limitation is that the results of the analyses were not adjusted for 
group differences. Although the number of cases in each group was unequal, it was 
assumed that there was no significant difference between the characteristics of the 
participants in the two groups. Another limitation is that the sample size was small. 
Moreover, no participants in the study have been diagnosed with prostate cancer. The 
patients who have diagnosis of prostate cancer and those who have not may have 
differences in their perceptions. Most of the data collected was also self-reported and 
could only be used to gauge individual perceptions. The results were not robust and 
cannot be used to create programs that target a larger population. 
Recommendations for Action 
 While the number of participants in this survey was adequate for data analysis, 
more participants would likely have yielded results that were more conclusive. As such, 
the conclusions in this study are applicable only to the narrow population that participants 
represented. Also, since most research has focused on European Americans, more 
research studies that look at reasons for the reluctance of African American males to 
schedule a PSA screening could be valuable for reaching this population.  
 The limited sample size might also be a reason there were no definitive 
conclusions regarding the relationships and interactions among the variables in both the 
control and intervention groups. Although the results of the analysis support the idea that 
the intervention was effective, the scores were too low to be statistically significant. 
Because of this, there is no way to attribute changes in knowledge or behavior to the 




a study that includes more data across a broader population. Future researchers who want 
to conduct a study on the same topic would be advised to use a larger number of 
participants from a broader demographic. 
 Another element that may have affected the behavior of participants—following 
through or failure to follow through with the intention to make a medical appointment for 
screening—was that the population identified by the database was not a cross section. 
Rather, it was business owners, a population that typically has more immediate 
responsibilities because of having to operate a company, and who might be less inclined 
to take the time to participate fully by carrying out the activities of the research. Indeed, 
many may have agreed and intended to comply with the requests for follow-up but 
discontinued the activities because of lack of time, loss of interest, or pressing business 
reasons. Because the participants discontinued their research activities, and they had been 
assured that they could do so without giving a reason and at any time, their reasons for 
quitting were not known.  
 One possible reason is that business owners, it may be inferred, have either health 
insurance or the financial resources to pay for the care they might need. This 
demographic would also be far more likely to have a private physician and would have 
been informed by him or her about prostate cancer, its warning signs, and the protocol to 
follow to know about their own health condition. As a result, they should have more and 
better information, either from their doctors or through reading, other kinds of support 




The effect on the information and the way it was presented on increased 
knowledge, although statistically significant, was very weak. Ironically, those in the 
intervention group actually demonstrated a decrease in knowledge. Therefore, the 
intervention participants’ increase in prostate screening knowledge did not account for 
the variation in knowledge change. It is possible that the educational intervention did not 
completely align with the PCKQ survey tool used to assess knowledge change. In 
addition, the use of the internet with African American males may not be the best method 
to increase their knowledge about prostate screening. More specifically, there has been a 
myriad of publicity about and many articles over the past 5 years on potentially negative 
effects of prostate cancer screening. In my opinion publicity about the potential harm of 
screening or from other conflicting information had has affected even males who had 
previously had a prostate screening. Because some men that had prior prostate screening 
knowledge and participated in a screening exam have been dissuaded regarding the 
benefits of screening, there is a need to better understand the impact that this information 
has had on African American men and how it might have influenced their decisions to 
participate in prostate screening exams.  
The United States Preventative Services Task Force (USPSTF) has issued draft 
recommendations that would eliminate early screening by telling health insurance 
policies to discontinue use of the PSA test. However, three issues that the preventive task 





1. Guidelines on office-based decisions about whether to initiate PSA screening 
require clinicians to discuss the benefits and harms of screening and to accept 
patients’ screening decisions.  
2. There is also the issue of variable and often idiosyncratic management of PSA 
levels in primary care and urology practices. The substantial variability in how 
clinicians manage serial PSA levels is understandable, since published guidelines 
are vague and offer little guidance. But the guidelines are vague precisely because 
the limitations of PSA screening preclude a rational, standardized, evidence-based 
algorithm that should inform any routine preventive intervention. Thus, 
physicians are left to decide—with the patient—whether there would be a benefit 
from screening. 
3. The third issue lies at the interface of clinical practice, public health, and 
responsible stewardship of health care resources. Although the USPSTF explicitly 
does not consider costs, policymakers cannot ignore economic aspects of 
screening, and neither can patients whose out-of-pockets may be high or whose 
health insurance coverage is inadequate (Brett & Ablin, 2011). 
There is a need to reexamine the behaviors of African American males regarding 
scheduling of PSA screening. Although participation in the study generated awareness 
and the potential intention for PSA screening, the factors hindering the positive behaviors 
of the population to seek or schedule for PSA screening were not revealed. The 




determine its contribution to the overall negative behaviors associated with seeking PSA 
schedule.  
Recommendations for Future Studies 
There are several ways future research might be constructed to learn more about 
the reasons African American men are not tested for prostate cancer as often as European 
American men. Because this study included a limited demographic that may or may not 
have been expected to respond to or participate in study activities in the same way as a 
broader cross section, it is not known whether variables such as urban or rural population, 
insured or lacking insurance, family history of prostate cancer, religious beliefs, and the 
degree of relationship with a private physician or health care clinic might affect 
participants’ decisions to seek or avoid learning about prostate cancer and screening. The 
results might provide insights into whether these variables are separate from ethnicity or 
are true across cultures. Similar studies of a Hispanic population might determine 
whether that culture includes unique factors that influence health care decisions. Through 
learning more about differing populations through additional studies, information that 
goes beyond language and is culture-specific might be created and potentially applied to 
developing outreach programs that could be tailored to different populations. 
Although African American men are at greater risk of dying from prostate cancer, 
whatever might be learned from future studies about the reasons some men choose not to 
be screened could inform protocols for how to educate men about screening and choice of 
screening type and how to discuss options with men from different social, educational, 




better ways of reaching and informing different populations about prostate cancer with 
the end of identifying the disease early when there is hope for life-saving treatment. 
Positive social change would occur as a direct result of reaching all men by means that 
were sensitive to their unique demographic characteristics and providing them with equal 
opportunities for lifesaving detection and treatment before the disease reaches an 
advanced stage and death is imminent. Knowing the most effective means of informing 
men of all cultures in a way that would prompt them to seek screening remains the 
challenge. 
Conclusions 
Providing information regarding prostate cancer could be a means for African 
American males to learn about the disease and thereby influence a decision to be 
screened, but pamphlets or Internet sites that provide the information might not be the 
most effective approach. It is not known if participants lost interest in the study or did not 
like the access to and format of the information that then were provided. While the 
intention of the African American males involved in the study was a significant effect of 
access to information, there are no probable demographic variables associated with their 
intention to be screened. Contrary to other studies, economic status and educational 
achievement among African American males were not shown to be significant predictors 
that affected their intention to pursue PSA screening.  
While the results suggested the possible relationships between access to 
information, gaining knowledge, and intention to screen, they did not prove that these 




health care provider. Although works of Jones (2007) can be used to explain the beliefs 
about PSA and DRE tests and the reluctance or willingness to be screened, negative 
behavior as an effect of negative perceptions of these tests remains to be empirically 
tested. Although the effects may be inferred from the literature, they cannot be deduced 
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Appendix A: Sample-size Calculator--G Power 
[1] -- Sunday, February 26, 2012 -- 20:12:30 
 
t tests - Means: Wilcoxon-Mann-Whitney test (two groups) 
Options: A.R.E. method 
Analysis: A priori: Compute required sample size  
Input: Tail(s) = Two 
 Parent distribution = Normal 
 Effect size d = 0.5 
 α err prob = 0.05 
 Power (1-β err prob) = 0.80 
 Allocation ratio N2/N1 = 1 
Output: Noncentrality parameter δ = 2.8279915 
 Critical t = 1.9789766 
 Df = 125.9606 
 Sample size group 1 = 67 
 Sample size group 2 = 67 
 Total sample size = 134 




Appendix B: Permission To Use Survey Tool 
Hello Dr. Weinrich: 
 
I am a PhD student at Walden University. I am writing you for permission to use your 
Prostate Cancer Knowledge Questionnaire 12 in my dissertation research. I am looking to 
research changes in African American male prostate cancer knowledge, behavior change, 
and screening behavior. I have attached a copy of my proposal abstract for your review.  
Thank you in advance for your consideration of my request. Kindly respond via email.  
Bev 
 
Note: I received your personal email address from Elizabeth (Beth) G. NeSmith, PhD, 





Yes, glad for you to use it.  
I suggest you add a question about screening for risk for CaP based on length of index 










Appendix C: Intent To Screen 
1. Now that you have reviewed the prostate cancer health information website, will 
you schedule an appointment for a PSA or DRE prostate cancer screening? 
 A. Yes 





Appendix D: Screening Behavior  
1. Two weeks have passed since you reviewed the prostate health information 








Appendix E: Demographic Questionnaire and Stages of Change 
1. What is your gender? 
1. Male  
2. Female 
2. What is your ethnicity? 
1. Asian 
2. African American 
3. European American 
4. Hispanic 
5. Other 
3. What is your highest level of formal education? 
1. Less than high school graduate 
2. High school graduate 
3. Some college 
4. 4-year degree 
5. Master’s degree or above 
4. What is your age? 
1. ___________years 
5. What is your approximate annual income? 
1. $___________ 








What kind of healthcare coverage do you have? 
3. None 
4. Medicare/Medicaid 
5. Veterans’ benefits 
6. Employer-sponsored or private insurance 
7. Please select the response that best describes your current interest in prostate 
screening (DRE – digital rectal exam and / or PSA – prostate specific antigen 
blood test):  




b. I have had at least one DRE and/or PSA in the past, but I am now off 
schedule and do not plan to have a DRE and/or PSA. 
c. I have never had a DRE and/or PSA, but I plan to have one or I am off 
schedule after having a prior DRE and/or PSA, but I intend to have one. 
d. I have had one DRE and/or PSA on schedule, and I intend to have another 
as scheduled. 
e. I have had at least 2 DREs and/or PSAs on schedule, and I intend to have 




Appendix F: Prostate Cancer Knowledge Questionnaire 
 
Please answer each of the following sentences with “True 







    
1. Men who have several family members (blood 
relatives) with prostate cancer are more likely to 
get prostate cancer. 
   
2. A man can have prostate cancer and have no 
problems or symptoms. 
   
3. Younger men are more likely to get prostate 
cancer than older men. 
   
4. Frequent pain in your lower back could be a sign 
of prostate cancer. 
   
5. Most 80-year-old men do not need a prostate 
cancer screening. 
   
6. Some treatments for prostate cancer may make 
it harder for men to control their urine. 
   
7. Some treatments for prostate cancer may cause 
problems with a man’s ability to have sex. 
   
8. Some treatments for prostate cancer may stop a 
man from ever driving a car again. 
   
9. Doctors can tell which men may die from 
prostate cancer and which men will not be 
harmed by prostate cancer. 
   
10.  An abnormal Prostate Specific Antigen (PSA) 
blood test means I have cancer for sure. 
   
11.  I can have cancer and have a normal PSA blood 
test. 
   
12.  Prostate cancer may grow slowly in some men.    
 
Note. True is the correct answer for questions 1, 2, 4, 5, 6, 7, 11, and 12. False is 
















Experienced, goal-oriented professional with a record of meeting and 
exceeding established goals related to marketing and sales, training 
and development, and client relations. 
Skilled in building long-term relationships within all levels of an 
organization. Motivated and ambitious with excellent interpersonal 




UnitedHealthcare, Milwaukee, Wisconsin. September 2010—present 
 
 
Senior Health Economic Consultant 
Analyze and evaluate national and key account business. Provide financial and clinical advice 
using Excel and Access company-branded reporting tools. Responsible for the development of 
annual and semi-annual client PowerPoint presentations. Manage the delivery of key findings 
based on clinical results and financial risk to capture best ROI. Assist strategic account 
executives in development of key relationships.  
 
Schering-Plough Pharmaceuticals, Kenilworth, New Jersey. April 2006--November 2008 
 
Senior Customer Marketing Manager 
Developed and implemented managed care pull-through and push-through in the Great Lakes 
Region for all product lines, including development of marketing collaterals to support regional 
management for sales of branded products such as Vytorin, Zetia, Nasonex, Asmanex, Avelox, 
Levitra, Pegintron, and new women’s health and anesthesia lines. Created relationships with 
managed care organizations, pharmacy benefits managers, and national account TARGET® 
around quality and disease-management initiatives. Assisted in the launch and development of 
quality client integration tools, service agreements, management of field integration, and 
managed-care pull-through. 
 
Takeda Abbott Pharmaceuticals, North Chicago, Illinois. October 2000--March 2006 






Senior Manager, Managed Markets Marketing and Strategy Created and managed 
marketing strategy for the integrated health channel supporting the Takeda Abbott 
Pharmaceutical health system, managers, and executives. This included development of 
marketing collaterals to support strategies and tactics for Prevacid and Lupron. Managed new 
product launches, disease awareness campaigns, and the development of medical education 
initiatives within the managed markets channel.  
 
Senior Managed Markets Trainer  
 
Designed curriculum and delivered managed care training, in collaboration with Marketing, 
Regulatory, Contracting and Medical Affairs divisions. Managed specialty product and initial 
sales training of Prevacid and Lupron product lines. Trainees included managed care 
executives, regional account managers, health systems executives, and state government 
account executives.  
 
Gastrointestinal Sales Specialist/District Managed-Care Specialist. Milwaukee, 
Wisconsin 
 
Managed Milwaukee market, growing GI annual sales of Prevacid and PrevPac by 4% in 
targeted gastroenterologists, primary care physicians, and hospitals. Designed and delivered 
managed-care education and industry updates for district. Excalibur ranked #10 awards: C.W. 
Hall Saiyushu for leading Prevacid scripts in 2000; Walk-the Walk: highest increase in Prevacid 
market share with targeted physicians.  
 
Abbott Laboratories, North Chicago, Illinois. June 1998--October 2000 
Anti-infective/Gastrointestinal Sales Specialist. Ann Arbor, Michigan 
 
Managed a $3.6 million territory in the Ann Arbor market while growing GI annual sales by 8% 
through marketing of Biaxin, Omnicef, Prevacid (proton pump Inhibitor) and PrevPac to 
community physicians and hospitals. Conducted managed care training seminars for physician 
accounts and Abbott district managers. Managed Henry Ford Medical Center accounts in 
territory.  
 
Part-time Pharmaceutical Sales Consultant 
 
Marketed antibiotics for respiratory tract infections to emergency and urgent care centers. 
Expanded account base by 100%. Grew annual territory sales by 10%.  
 
Spring Arbor University, Spring Arbor, Michigan. January 1995--October 2000 
Associate Professor  
 
Faculty member, Management of Health Services and Management of Organizational 
Development departments. Responsible for curriculum development and strategic marketing of 
the MHS accelerated degree program. Coordinated internships and counseling. Course content 
knowledge included the following:  
 
 Health Services Systems and Environments (includes managed care) 
 Biological, Psychological and Social Aspects of Health Care 
 Administration in Health Care Services (includes managed care) 
 Health Services Management and Supervision 
 Health Services Programs - Design and Implementation 
 Policy and Ethical Issues in Health Care 




Multimedia Consulting Group, Ann Arbor, Michigan. June 1992--June 1998  
Partner/Business Development Manager  
 
Started company while in graduate school to provide multimedia services and organizational 
development training to health care organizations. Created and coordinated interactive 
computer-based training, presentation graphics, and video production. Training expertise 
included coaching techniques, computer/software training, strategic planning, creative 
planning sessions ”storyboarding,” diversity, and power and influence. Managed daily 
operations, training, and marketing. 
 
Bristol-Myers Squibb, USPNG, Evansville, Indiana. September 1990--May 1992  
Oncology Sales Specialist 
 
Managed $8.5 million dollar territory including major teaching institutions in Detroit, Michigan. 
Trained medical residents, fellows, nurses and research specialist on innovative chemotherapy 
procedures. Coordinated Grand Rounds and Fellow development programs. Managed funding 
for research projects at major teaching institutions. Grew annual sales by 20%.  
 
Parke-Davis, Morris Plains, New Jersey. December 1988--September 1990 
Hospital Sales Specialist/Account Team Manager/Cardiovascular Sales Specialist 
 
Managed $6.5 million dollar territory. Grew annual sales by 25%. Managed and coordinated 
sales activities of 12 specialty sales representatives (OB/GYN, neurological, cardiovascular, 
and primary care specialists). Conducted monthly meetings with account team members to 
formulate marketing strategies. Trained medical residents, fellows, nurses, and research 




Walden University, Baltimore, Maryland  
PhD (ABD), Public Health/Community Health  
 
University of Michigan, Ann Arbor  
MS in Public Health Policy and Administration: Marketing and strategic planning. 
 
 President, Public Health Student Association 
 Full scholarship fellow 
 Toastmasters International 
 Student keynote speaker at graduation 
 
Ursuline College, Pepper Pike, Ohio  
BA, Health Administration; Minor, Nursing  
 
 Coordinator, intramural and aquatic activities 
 Board of Academic Accreditation, student representative 




 Christian Faith Fellowship Church graduation keynote speaker--2008 
 Spring Arbor University graduation keynote presenter--2003 and 2004 
 Jesus Name Apostolic Church prostate cancer awareness and education presenter--2011 
 
